penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Ronald P. DeMatteo, MD, FACS
Department of Surgery

 
  • Profile Home
  • Appointments
  • Education
  • Societies
  • Research
  • Publications
  • Awards

Office:
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Administrative Assistant: Mayuli Arthur
Telephone: 215-662-7539
Fax: 215-614-0363

Contact Information (internal use only)

ronald.dematteo@uphs.upenn.edu

 

Dr. DeMatteo is the Chairman of the Department of Surgery and a surgical oncologist who specializes in treating men and women with diseases of the liver, bile duct, gallbladder, and pancreas.

His clinical research has focused on liver, bile duct, gallbladder, and pancreas cancers. In addition, he has led several national trials testing the benefit of imatinib mesylate (Gleevec) following surgery for gastrointestinal stromal tumor (GIST), a tumor that usually begins in the stomach or intestine.

In the laboratory he and his colleagues study the immune environment of the liver and tumor immunology, working to develop immune therapies to help prevent tumors from returning after surgery.

 
Faculty Appointments
2017 - present John Rhea Barton Professor and Chairman
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 
2012 - 2017 Associate Dean
Weill Medical College of Cornell University
New York, New York
 
2008 - 2017 Joint Appointment, Immunology Program
Sloan Kettering Institute
New York, New York
 
2008 - 2017 Professor of Surgery
Weill Medical College of Cornell University
New York, New York
 
2007 - 2017 Member (with tenure of title)
Memorial Sloan Kettering Cancer Center
New York, New York
 
2005 - 2007 Associate Professor of Surgery
Weill Medical College of Cornell University
New York, New York
 
2004 - 2007 Associate Member
Memorial Sloan Kettering Cancer Center
New York, New York
 
2000 - 2005 Assistant Professor of Surgery
Weill Medical College of Cornell University
New York, New York
 
1999 - 2004 Assistant Member
Memorial Sloan Kettering Cancer Center
New York, New York
 
Hospital and/or Administrative Appointments
2017 - present Chairman, Department of Surgery
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 
2009 - 2017 Leslie H. Blumgart Chair in Surgery
Memorial Sloan Kettering Cancer Center
New York, New York
 
2007 - 2017 Attending Surgeon, Hepatopancreatobiliary Service
Department of Surgery, Memorial Hospital
New York, New York
 
2006 - 2017 Head, Division of General Surgery Oncology
Department of Surgery, Memorial Hospital
New York, New York
 
2006 - 2017 Vice Chair, Department of Surgery
Memorial Hospital
New York, New York
 
2004 - 2007 Associate Attending Surgeon, Hepatobiliary Service
Department of Surgery, Memorial Hospital
New York, New York
 
1999 - 2004 Assistant Attending Surgeon, Hepatobiliary Service
Department of Surgery, Memorial Hospital
New York, New York
 
Education/Training
1990 MD - Weill Medical College of Cornell University
 
1986 BA - The John Hopkins University
 
Postgraduate Training and Fellowship Appointments
1998 - 1999 David and Monica Gorin Sarcoma Research Fellow
Murray F. Brennan MD Memorial Hospital
New York, New York
 
1997 - 1999 Fellow, Surgical Oncology
Memorial Sloan Kettering Cancer Center
New York, New York
 
1995 - 1997 Postdoctoral Fellow, Immunology and Transplantation, Clyde F. Barker, MD
University of Pennsylvania
Philadelphia, Pennsylvania
 
1993 - 1995 Postdoctoral Fellow, Molecular Biology and Virology
Steven E. Raper, MD and James M. Wilson, MD, PhD
University of Pennsylvania
Philadelphia, Pennsylvania
 
1991 - 1997 General Surgery Resident
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
1990 - 1991 General Surgery Intern
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
Memberships/Societies
International
2016 Grant Reviewer, German Research Foundation
 
2013 - present International Surgical Group (ISG)
 
2013 - 2016 Grant Reviewer, French National Cancer Institute (INCa)
 
2012 Grant Reviewer, Ontario Institute for Cancer Research Clinician Scientist Investigator Award
 
2010 - present James IV Association of Surgeons
 
2008 European Society of Medical Oncology Consensus Guidelines for the Treatment of GIST
 
2006 Gleevec Medical Affairs Gastointestinal Stromal Tumor Advisory Board, Novartis
 
National
2016 - present Society for Immunotherapy of Cancer
 
2015 - present American Society of Clinical Investigation
 
2015 American Joint Commission on Cancer (AJC) Staging Guidelines for GIST (Leader)
 
2015 American Association for Cancer Research Cancer Progress Report 2015 Steering Committee
 
2013 Grant Reviewer, Pancreatic Cancer Action Network (PanCAN)- AACR Grants
 
2013 - 2020 Cancer Immunology and Immunotherapy (CII) Study Section, NIH (Ad hoc 2013, 2015, Member 2016-20)
 
2012 - present K08 Committee for Steven Katz, Roger Williams Cancer Center
 
2012 - present Gastrointestinal Stromal Tumor Task Force, National Cancer Institute
 
2011 P01 Review Panel, National Institute of Diabetes and Digestive and Kidney Diseases(NIDDK)
 
2010 - 2011 Gastrointestinal Stromal Tumor Working Group, National Cancer Institute
 
2009 Alliance for Cancer Gene Therapy
 
2008 - present American Surgical Association (Flance/Karl Award Committee Chair 2014-2015)
 
2007 - present Society of Clinical Surgery
 
2005 - 2006 Hepatobiliary Pathophysiology (HBPP) Study Section, (NIH)
 
2004 - present Surgical Biology Club I
 
2004 - present Society of University Surgeons
 
2004 - 2009 National Comprehensive Cancer Network (NCCN) Guidelines Committee for the Treatment of Gastrointestinal Stromal Tumor (2004, 2007, 2009)
 
2003 State of the Science Meeting on Sarcoma, National Institutes of Health(NIH)
 
2003 National Comprehensive Cancer Network (NCCN) Guidelines Committee for the Treatment of Hepatobiliary Cancer
 
2002 - present American Society of Clinical Oncology
 
2001 National Institutes of Health (NIH) Workshop on Gastrointestinal Stromal Tumors
 
2001 - present American Hepatopancreatobiliary Association
 
2000 - present Society of Surgical Oncology (Co-Chair, Molecular Therapy Symposium 2004, Chair, Clinical Affairs Committee 2004-2005, Training Program Directors Subcommittee 2006-13, American Board of Surgery Advisory Task Force 2007, Executive Council, Councillor-at-Large 2008-11, Co-Chair, GIST Symposium 2008, Scientific Program Committee 2009-12, SSO Retreat 2010)
 
2000 - present Society for Surgery of Alimentary Tract
 
2000 National Institutes of Health (NIH) Conference on STI571 for Gastrointestinal Stromal Tumor
 
2000 - present Association of Academic Surgeons
 
2000 - present American College of Surgeons
 
2000 - present American Association of Immunologists
 
2000 - present American Association for Study of Liver Diseases
 
2000 - present American Association for Cancer Research
 
1999 - 2011 American College of Surgeons Oncology Group (Sarcoma Study Group 1999-2006, Audit Committee 2001-03, Constitution and Bylaws Committee 2003-04, Gastrointestinal Study Group 2006-11, Basic Science Chair Search Committee 2008, Site Visit Participant 2008, '10.)
 
Locals
2016 - present External Advisory Board, T32 in Hematology/Medical Oncology, Columbia University
 
2013 Grant Reviewer, Empire Clinical Research Investigator Program (ECRIP), New York State
 
Research
Research Publications, peer reviewed (print or other media)
  1. DeMatteo RP, Markmann JF, Raper SE: An improved technique of thymectomy in the adult mouse. Transplantation 59: 787-9, 1995.
  2. DeMatteo RP, Raper SE, Ahn M, Fisher KJ, Burke C, Radu A, Widera G, Claytor BR, Baker CF, Markmann JF: Gene therapy to the thymus: A means of abrogating the immune response to recombinant adenovirus. Ann Surg 222: 229-42, 1995.
  3. Raper SE, Kothary P, Ishoo E, Dikin M, Kokudo N, Hashimoto M, DeMatteo RP: Divergent mechanisms of insulin-like growth factor I and II on rat hepatocyte DNA proliferation. Regul Pept 58: 55-62, 1995.
  4. DeMatteo RP, Markmann JF, Kozarsky K, Barker CF, Raper SE: Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther 3: 4-12, 1996.
  5. Fisher KJ, Gao GP, Weitzman M, DeMatteo RP, Burda JF, Wilson JM.: Transduction with recombinant adeno-associated virus for gene therapy is limited by leading strand synthesis. J Virol 70: 520-32, 1996.
  6. Raper SE, DeMatteo RP: Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 12: 401-10, 1996.
  7. Velázquez OC, Jabbar A, DeMatteo RP, Rombeau JL: Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice. Surgery 120: 440-8, 1996.
  8. DeMatteo RP, Chu G, Ahn M, Chang E, Barker CF, Markmann JF: Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 71: 5330-35, 1997.
  9. DeMatteo RP, Chu G, Ahn M, Chang E, Burke C, Raper SE, Barker CF, Markmann JF: Immunologic barriers to hepatic adenoviral gene therapy for transplantation. Transplantation 63: 315-9, 1997.
  10. DeMatteo RP, McClane SJ, Fisher KJ, Yeh H, Chu G, Burke C, Raper SE: Engineering tissue-specific expression of a recombinant adenovirus: Selective transgene transcription in the pancreas using the amylase promoter. J Surg Res 72: 155-61, 1997.
  11. Hamilton TE, DMatteo RP, McClane SJ, Burke C, Rombeau JL, Raper SE: Adenoviral-mediated gene transfer to murine small intestine is more efficient in neonates than adults. J Ped Surg 32: 373-7, 1997.
  12. McClane SJ, Hamilton TE, DeMatteo RP, Burke C, Raper SE: Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse. Pancreas 15: 236-45, 1997.
  13. Judge TA, Desai NM, Yang Z, Rostami S, Alonso L, Zhang H, Chen Y, Markmann JF, DeMatteo RP, Barker CF, Naji A, Turka LA: Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 66: 426-34, 1998.
  14. DeMatteo RP, Yeh H, Friscia M, Caparrelli D, Burke C, Desai N, Chu G, Markmann JF, Raper SE, Barker CF: Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases. Ann Surg Oncol 6: 88-94, 1999.
  15. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231: 51-8, 2000.
  16. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y: Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4: 178-84, 2000.
  17. Fong Y, Jarnagin W, Conlon KC, DeMatteo RP, Dougherty E, Blumgart LH: Hand-assisted laparoscopic live resection. Arch Surg 135: 854-9, 2000.
  18. Weber SM, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y: Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7: 643-50, 2000.
  19. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y, Blumgart LH: Management of 155 patients with benign liver tumours. Br J Surg 88: 808-13, 2001.
  20. Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF: Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 8: 290-99, 2001.
  21. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF: Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234: 540-48, 2001.
  22. Jarnagin W R, Conlon K, Bodniewicz J, Dougherty E, DeMatteo RP, Blumgart LH, Fong Y: A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91: 1121-8, 2001.
  23. Jarnagin WR, Bach AM, Winston CB, Hann LE, Heffernan N, Loumeau T, DeMatteo RP, Fong Y, Blumgart LH: What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg 192: 577-83, 2001.
  24. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BSJ, Youssef BAM, Klimstra D, Blumgart LH: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234: 507-19, 2001.
  25. Martin RC, Fong Y, DeMatteo RP, Brown K, Blumgart LH, Jarnagin WR: Peritoneal washings are not predictive of occult peritoneal disease in patients with hilar cholangiocarcinoma. J Am Coll of Surg 193: 620-25, 2001.
  26. Melendez J, Ferri E, Zwillman M, Fischer M, DeMatteo RP, Leung D, Jarnagin W, Fong Y, Blumgart LH: Extended hepatic resection: A 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 192: 47-53, 2001.
  27. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH: Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193: 384-91, 2001.
  28. Wong RJ, Patel SG, Kim S, DeMatteo RP, Malhotra S, Bennett JJ, St-Louis M, Shah JP, Johnson PA, Fong Y: Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther 12: 253-65, 2001.
  29. Burt B, Brown K, Jarnagin W, DeMatteo RP, Blumgart LH, Fong Y: An audit of results of a no-drainage practice policy after hepatectomy. Am J Surg 184: 441-45, 2002.
  30. D'Angelica M, Jarnagin WR, DeMatteo RP, Conlon K, Blumgart LH, Fong Y.: Staging laparoscopy for potentially resectable non-colorectal, non-neuroendocrine liver metastases. Ann Surg Oncol 9: 204-9, 2002.
  31. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH: Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade. Ann Surg 236: 397-407, 2002.
  32. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D: Combined hepatocellular and cholangiocarcinoma: Demographic, clinical, and prognostic factors. Cancer 94: 2040-46, 2002.
  33. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y: Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 6: 88-94, 2002.
  34. Miller G, Lahrs S, Pillarisetty VG, Shah AB, DeMatteo RP: Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res 62: 5260-65, 2002.
  35. Miller G, Pillarisetty VG, Shah AB, Lahrs S, Xing Z, DeMatteo RP: Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. Immunol 169: 2875-85, 2002.
  36. Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo RP, Heinrich S, Encke A, Blumgart LH, Fong Y: Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann Surg 235: 863-71, 2002.
  37. Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 235: 392-99, 2002.
  38. Allen PJ, Kemeny N, Jarnagin WR, DeMatteo RP, Blumgart L, Fong Y: Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7: 109-17, 2003.
  39. Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP, Besmer P: Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 9: 3329-37, 2003.
  40. Boffa DJ, Fang B, Sharma V, DeMatteo RP, Miller G, Suthanthiran M, Nunez R, Liou H-C: Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. Cell Immunol 222: 105-15, 2003.
  41. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP: Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197: 753-8, 2003.
  42. Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP: Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 238: 315-23, 2003.
  43. D'Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K, Blumgart LH, Jarnagin WR.: A prospective analysis of staging laparoscopy in 401 patients with primary and secondary hepatobiliary malignancies. Ann Surg Oncol 40: 144-93, 2003.
  44. Jarnagin WR, Ruo Leyo, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 98: 1689-700, 2003.
  45. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, DeMatteo RP, D'Angelica M, Blumgart LH, Jarnagin WR: Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7: 1034-44, 2003.
  46. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, DeMatteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y: Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237: 860-70, 2003.
  47. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo RP, Jarnagin W, Blumgart: Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197: 233-42, 2003.
  48. Martin Robert C G, Jarnagin William R, Fong Yuman, Biernacki Peter, Blumgart Leslie H, DeMatteo Ronald P: The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: Is there a standard for transfusion? J Am Coll Surg 196: 402-9, 2003.
  49. Miller G, Lahrs S, DeMatteo RP: Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity. FASEB J 17: 28-30, 2003.
  50. Miller G, Lahrs S, Shah AB, DeMatteo RP: Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus. Cancer Immunol Immunother 52: 347-58, 2003.
  51. Miller G, Pillarisetty VG, Shah AB, Lahrs S, DeMatteo RP: Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. J Immunol 170: 3554-64, 2003.
  52. Pillarisetty VG, Miller G, Shah AB, DeMatteo RP: GM-CSF expands dendritic cells and their progenitors in mouse liver. Hepatology 37: 641-52, 2003.
  53. Schwartz LH, Lefkowitz RA, Panicek DM, Coakley FV, Jarnagin W, DeMatteo RP, Fong Y, Blumgart LH: Breath-hold magnetic resonance cholangiopancreatography in the evaluation of malignant pancreaticobiliary obstruction. J Comput Assist Tomogr 27: 307-14, 2003.
  54. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y: Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7: 325-30, 2003.
  55. Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, DeMatteo RP: Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll of Surg 197: 392-402, 2003.
  56. Yoon SS, Jarnagin WR, Fong Y, DeMatteo RP, Barakat RR, Blumgart LH, Chi DS: Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol Oncol 91: 383-88, 2003.
  57. Antonescu CR, Viale A, Sarran L, Tschernyavsky SJ, Gonen M, Segal NH, Maki RG, Socci ND, DeMatteo RP, Besmer P: Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res 10: 3282-90, 2004.
  58. Bleier JI, Pillarisetty VG, Shah AB, DeMatteo RP: Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow. J Immunol 172: 7408-16, 2004.
  59. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, DeMatteo RP, Poynor EA, Abu-Rustum NR, Barakat RR: Improved optimal cytoreduction rates for stage IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach. Gynecol Oncol 94: 650-54, 2004.
  60. D'Angelica M, Martin RCG, Jarnagin WR, Fong Y, DeMatteo RP, Blumgart LH: Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg 198: 570-76, 2004.
  61. Granitto SR, Kolachana P, Antonescu CR, Johnson RC, DeMatteo RP, Jhanwar SC: Genomic alterations in gastrointestinal stromal tumors as revealed by conventional and array-based comparative genomic hybridization. Cancer Genom Proteom 1: 105-6, 2004.
  62. Grobmyer SR, Fong Y, D'Angelica , Dematteo RP, Blumgart LH, Jarnagin WR: Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg 139: 1326-30, 2004.
  63. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y: Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11: 310-5, 2004.
  64. Katz Steven C, Pillarisetty Venu G, Bleier Joshua I, Shah Alaap B, DeMatteo Ronald P: Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol 173: 230-35, 2004.
  65. Miller G, Bleier JI, Antonescu C, Pillarisetty VG, Shah AB, Lahrs S, DeMatteo RP: Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression. Int J Cancer 110: 395-402, 2004.
  66. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP: Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 172: 1009-17, 2004.
  67. Weitz J, D'Angelica M, Jarnagin WR, Gonen M, Fong Y, Blumgart LH, DeMatteo RP.: Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. Surgery 135: 273-81, 2004.
  68. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP: Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 22: 4182-90, 2005.
  69. Corvera C, Darvishian F, Klimstra DS, DeMatteo RP, Fong Y, D'Angelica M, Blumgart LH, Jarnagin WR: Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg 201: 862-69, 2005.
  70. Hawkins WG, DeMatteo RP, Cohen MS, Jarnagin WR, Fong Y, D'Angelica M, Gonen M, Blumgart LH: Caudate hepatectomy for cancer: A single institution experience with 150 patients. J Am Coll Surg 200: 345-52, 2005.
  71. Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH: Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241: 703-14, 2005.
  72. Katz SC, Pillarisetty VG, Bleier JI, Kingham TP, Chaudhry UI, Shah AB, DeMatteo RP: Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology 42: 293-300, 2005.
  73. Kemeny N, Fong Y, Jarnagin W, Gonen M, Schwartz L, Paty P, Leonard G, Morse M, D'Angelica M, DeMatteo RP, Blumgart L: Phase I trail pf systemic oxaliplatin combinations with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23: 4888-96, 2005.
  74. Maluccio M, Covey AM, Ghandi R, Gonen M, Getrajdman G, Brody L, Fong Y, Jarnagin W, Blumgart LH, DeMatteo RP, Brown KT: Combined arterial embolization and ablation is comparable to surgical resection for treating patients with solitary heptocellular up to 7 cm. J Vasc Intervent Radiol 16: 955-61, 2005.
  75. Pillarisetty VG, Katz SC, Bleier JI, Shah AB, DeMatteo RP: Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12. J Immunol 174: 2612-18, 2005.
  76. Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P, Antonescu CR: Gastrointestinal stromal tumors in children and young adults: A clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Ped Hematol Oncol 27: 179-87, 2005.
  77. Torres U, Hawkins WG, Antonescu CR, Dematteo RP: Hepatic follicular dendritic cell sarcoma without Epstein-Barr virus expression. Arch Path Lab Med 129: 1480-83, 2005.
  78. Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE, DeMatteo RP: Hepatectomy for metastases from non-colorectal, non-neuroendocrine carcinoma. Ann Surg 241: 269-76, 2005.
  79. Agaram NP, Baren Ann, Arkun K, Dematteo RP, Besmer P, Antonescu CR: Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors. Ultrastruct Pathol 30: 443-52, 2006.
  80. Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, Brennan MF: A selective approach to the resection of cystic lesions of the pancreas: Results from 539 consecutive patients. Ann Surg 244: 572-82, 2006.
  81. Are C, Gonen M, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Differential diagnosis of proximal biliary obstruction. Surgery 140: 756-63, 2006.
  82. Bleier JI, Katz SC, Chaudhry UI, Pillarisetty VG, Kingham TP, Shah AB, Raab JR, DeMatteo RP: Biliary obstruction selectively expands and activates liver myeloid dendritic cells. J Immunol 176: 7189-95, 2006.
  83. Chaudhry UI, Katz SC, Kingham TP, Pillarisetty VG, Raab Jesse R, Shah AB, DeMatteo RP: In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells. FASEB J 20: 982-84, 2006.
  84. Chaudhry UI, Kingham TP, Plitas G, Katz SC, Raab JR, DeMatteo RP: Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth. Cancer Res 66: 10497-504, 2006.
  85. D'Angelica M, Maddineni S, Fong Y, Martin RCG, Cohen MS, Ben-Porat L, Gonen M, DeMatteo RP, Blumgart LH, Jarnagin WR: Optimal abdominal incision for partial hepatectomy: Increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J of Surg 30: 410-8, 2006.
  86. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D'Angelica MI, Barakat RR, Chi DS: The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 103: 1083-90, 2006.
  87. Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D'Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR: Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244: 260-64, 2006.
  88. Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D'Angelica M, Blumgart LH, Singh B: Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: Correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24: 1152-60, 2006.
  89. Maluccio MA, Covey AM, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, DeMatteo RP, Brown KT: Treatment of metastatic sarcoma o the liver with bland embolization. Cancer 107: 1617-23, 2006.
  90. Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D'Angelica M, Abou-Alfa G, Blumgart LH, DeMatteo RP: Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 106: 1331-38, 2006.
  91. Yoon SS, Kim SH, Gonen Mithat, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP: Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13: 353-62, 2006.
  92. Agaram NP, Besmer P, Wong GC, Guo T, Socci ND, Maki RG, DeSantis D, Brennan MF, Singer S, DeMatteo RP, Antonescu CR: Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors. Clin Cancer Res 13: 170-81, 2007.
  93. Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M: The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246: 295-300, 2007.
  94. Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG: MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med 204: 1891-900, 2007.
  95. Chaudhry UI, Plitas G, Burt BM, Kingham TP, Raab JR, DeMatteo RP: NK dendritic cells expanded in IL-15 exhibit antitumor responses in vivo. J Immunol 179: 4654-60, 2007.
  96. D'Angelica M, Kornprat P, Gonen M, Chung KY, Jarnagin WR, DeMatteo RP, Fong Y, Kemeny N, Blumgart LH, Saltz LB: Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study. Ann Surg Oncol 14: 759-65, 2007.
  97. Dalal KM, Woo Y, Galanis C, Gonen M, Tang L, Allen P, DeMatteo RP, Fong Y, Coit DG: Detection of micrometastases in peritoneal washings of pancreatic cancer patients by the reverse transcriptase. J Gastrointest Surg 11: 1598-605, 2007.
  98. DeMatteo RP, Maki RG, Singer S, Gonen M, Brennan MF, Antonescu CR: Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 245: 347-52, 2007.
  99. Ferrone CR, Tang LH, D'Angelica M, DeMatteo RP, Blumgart LH, Klimstra DS, Jarnagin WR: Extrahepatic bile duct carcinoid tumors: Malignant biliary obstruction with a good prognosis. J Am Coll Surg 205: 357-61, 2007.
  100. Francone TD, Landmann RG, Chen CT, Sun MY, Kuntz EJ, Zeng Z, DeMatteo RP, Paty PB, Weiser MR: Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met-expressing tumors. Mol Cancer Ther 6: 1460-6, 2007.
  101. Gold JS, van der Zwan SM, Gonen M, Maki RG, Singer S, Brennan MF, Antonescu CR, DeMatteo RP: Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Ann Surg Oncol 14: 134-42, 2007.
  102. Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR: Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer Res 13: 4874-81, 2007.
  103. House MG, Gönen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y, Brennan MF, Allen PJ: Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11: 1549-55, 2007.
  104. Kingham TP, Chaudhry UI, Plitas G, Katz SC, Raab J, DeMatteo RP: Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion. Hepatology 45: 445-54, 2007.
  105. Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M: Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg 142: 1087-92, 2007.
  106. Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M: Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14: 1151-60, 2007.
  107. Miller G, Biernacki P, Kemeny N, Gonen M, Downey R, Jarnagin WR, D'Angelica M, Fong Y, Blumgart LH, DeMatteo RP: Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205: 231-8, 2007.
  108. Park JO, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Wuest D, Blumgart LH, Jarnagin WR: Autologous versus allogeneic transfusions: No difference in perioperative outcome after partial hepatectomy. Autologous transfusion on hepatectomy outcome. J Gastrointest Surg 11: 1286-93, 2007.
  109. Parks R, Gonen M, Kemeny N, Jarnagin WR, D'Angelica M, Dematteo RP, Garden OJ, Blumgart LH, Fong Y: Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases. J Am Coll Surg 204: 753-61, 2007.
  110. Plitas G, Burt BM, Stableford JA, Nguyen HM, Welles AP, DeMatteo RP: Dendritic cells are required for effective cross-presentation in the murine liver. Hepatology 47: 1343-1351, 2007.
  111. Plitas G, Chaudhry UI, Kingham TP, Raab JR, DeMatteo RP: NK dendritic cells are innate immune responders to Listeria monocytogenes infection. J Immunol 178: 4411-6, 2007.
  112. Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, Ojogun N, Rockey DC, DeMatteo RP, Munford RS: A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem 282: 13726-35, 2007.
  113. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25: 4575-80, 2007.
  114. Weitz J, Klimstra DS, Cymes K, Jarnagin WR, D'Angelica M, La QMP, Fong Y, Brennan MF, Blumgart LH, DeMatteo RP: Management of Primary liver sarcomas. Cancer 109: 1391-96, 2007.
  115. White RR, Avital I, Sofocleous CT, Brown KT, Brody LA, Covey A, Getrajdman GI, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M: Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 11: 256-63, 2007.
  116. Winston CB, Lee NA, Jarnagin WR, Teitcher J, DeMatteo RP, Fong Y, Blumgart LH: CT angiography for delineation of celiac and superior mesenteric artery variants in patients undergoing hepatobiliary and pancreatic surgery. AJR Am J Roentgenol 189: W13-9, 2007.
  117. Agaram NP, Laquaglia MP, Ustun B, Guo T, Wong GC, Socci ND, Maki RG, DeMatteo RP, Besmer P, Antonescu CR: Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Can Res 14: 3204-15, 2008.
  118. Agaram NP, Wong GC, Guo T, Maki RG, Singer S, DeMatteo RP, Besmer P, Antonescu CR: Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 47: 853-9, 2008.
  119. Allen PJ, Reiner AS, Gonen M, Klimstra DK, Blumgart LH, Brennan MF, D'Angelica M, DeMatteo RP, Fong Y, Jarnagin WR: Extrahepatic cholangiocarcinoma: A comparison of patinets with resected proximal and distal lesion. HPB 10: 341-6, 2008.
  120. Bennett JJ, Schmidt CR, Klimstra DS, Grobmyer SR, Ishill NM, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Ann Surg Oncol 15: 1130-6, 2008.
  121. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG: Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455: 804-7, 2008.
  122. Burt BM, Plitas G, Nguyen HM, Stableford JA, Bamboat ZM, DeMatteo RP: Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function. Human Immunol 69: 469-74, 2008.
  123. Burt BM, Plitas G, Stableford JA, Nguyen HM, Bamboat ZM, Pillarisetty VG, DeMatteo RP: CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol 84: 1039-46, 2008.
  124. Cho CS, Curran S, Schwartz LH, Kooby DA, Klimstra DS, Shia J, Munoz A, Fong Y, Jarnagin WR, DeMatteo RP, Blumgart LH, D'Angelica MI: Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg 206: 480-8, 2008.
  125. Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D'Angelica MI, Blumgart LH, DeMatteo RP.: A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg 206: 281-91, 2008.
  126. Cho CS, Labow DM, Tang L, Klimstra DS, Loeffler AG, Leverson GE, Fong Y, Jarnagin WR, D'Angelica MI, Weber SM, Blumgart LH, DeMatteo RP: Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms. Cancer 113: 126-34, 2008.
  127. Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D'Angelica M, Fong Y, Jarnagin WR: 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206: 57-65, 2008.
  128. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D'Angelica M, Getrajdman GI, DeMatteo RP, Kemeny NE, Fong Y: Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247: 451-5, 2008.
  129. DeMatteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR: Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 112: 608-15, 2008.
  130. Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D'Angelica M, DeMatteo RP, Blumgart LH, O'Reilly EM: Gallbladder cancer(GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 98: 485-489, 2008.
  131. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR: Intrahepatic cholangiocarcinoma: Rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248: 84-96, 2008.
  132. Endo I, House MG, Klimstra DS, Gönen M, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 15: 2104-12, 2008.
  133. Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D'Angelica M: Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: Trends in treatment over time in 440 patients. Ann Surg 247: 109-117, 2008.
  134. Grobmyer SR, Hollenbeck ST, Jaques DP, Jarnagin WR, DeMatteo RP, Coit DG, Blumgart KH, Brennan MF, Fong Y: Roux-en-Y reconstruction after pancreaticoduodenectomy. Arch Surg 143: 1184-8, 2008.
  135. Ito H, Are C, Gonen M, D'Angelica M, DeMatteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR: Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247: 994-1002, 2008.
  136. Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, DeMatteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M: A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg 248: 360-9, 2008.
  137. Kattan MW, Gonen M, Jarnagin WR, DeMatteo RP, D'Angelica M, Blumgart LH, Fong Y: A nomogram fro predicting disease-specific survival after hepatic resection for metastases colorectal cancer. Ann Surg 247: 282-287, 2008.
  138. Maithel SK, Maloney S, Winston C, Gönen M, D'Angelica MI, DeMatteo RP, Jarnagin WR, Brennan MF, Allen PJ: Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol 15: 3512-20, 2008.
  139. Maluccio MA, Covey AM, Porat LB, Schubert J, Bridy LA, Sofocleus CT, Getradjman GI, Jarnagin W, DeMatteo RP, Blumgart LH, Fong Y, Brown KT.: Transcatheter arterial embolization with only particles for the treatment of unresectabe hepatocellular carcinoma. J Vasc Interv Radiol 19: 862-9, 2008.
  140. Plitas G, Burt BM, Nguyen HM, Bamboat ZM, DeMatteo RP: Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J Exp Med 205: 1277-83, 2008.
  141. Sofocleous CT, Nascimento RG, Petrovic LM, Klimstra DS, Gonen M, Brown KT, Brody LA, Covey AM, Thornton RH, Fong Y, Solomon SB, Schwartz LH, DeMatteo RP, Getrajdman GI: Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: Initial results. Radiology 249: 364-74, 2008.
  142. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, Gonen M, Young JW, DeMatteo RP: Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 182: 1901-11, 2009.
  143. Burt BM, Plitas G, Zhao Z, Bamboat ZM, Nguyen HM, Dupont B, DeMatteo RP: The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors. J Immunol 183: 1789-96, 2009.
  144. Carpizo DR, Are C, Jarnagin W, DeMatteo RP, Fong Y, Gonen  M, Blumgart L, D'Angelica M: Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: Results in 127 patients treated at a single center. Ann Surg Oncol 16: 2138-46, 2009.
  145. D'Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 16: 806-16, 2009.
  146. DeMatteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PWT, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K: Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: A randomised, double-blind, placebo-controlled trial. The Lancet 373: 1097-104, 2009.
  147. Fahy BN, D'Angelica M, DeMatteo RP, Blumgart LH, Weiser MR, Ostrovnaya I, Gonen M, Jarnagin WR: Synchronous hepatic metastases from colon cancer: Changing treatment strategies and results of surgical intervention. Ann Surg Oncol 16: 361-70, 2009.
  148. Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, DeMatteo RP, D'Angelica M, Fong Y, Jarnagin WR, Allen PJ, Kemeny N: Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. Ann Surg Oncol 16: 1844-51, 2009.
  149. Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP: Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumor: A retrospective analysis. Lancet Oncol 10: 1045-52, 2009.
  150. Guo T, Hajdu M, Agaram NP, Shinoda H, Veach D, Clarkson BD, Maki RG, Singer S, DeMatteo RP, Besmer P, Antonescu CR: Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance. Clin Cancer Res 15: 6862-70, 2009.
  151. Ito H, Hann LE, D'Angelica M, Allen P, Fong Y, DeMatteo RP, Klimstra DS, Blumgart LH, Jarnagin WR: Polypoid lesions of the gallbladder: Diagnosis and followup. J Am Coll Surg 208: 570-5, 2009.
  152. Ito K, Ito H, Are C, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR, D'Angelica MI: Laparoscopic versus open liver resection: A matched-pair case control study. J Gastrointest Surg 13: 2276-83, 2009.
  153. Jarnagin WR, Schwartz LH, Gonen M, Gultekin  DH, Haivland D, Shia J, D'Angelica M, Fong Y, DeMatteo RP, Tse A, Blumgart LH, Kemeny K: Regional chemotherapy for unresectable primary liver cancer: Results of a Phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 20: 1589-95, 2009.
  154. Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, Jarnagin W, Fong Y, Blumgart L, D'Angelica M, DeMatteo RP: T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol 16: 2524-30, 2009.
  155. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, DeMatteo RP: Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249: 617-23, 2009.
  156. Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, DeMatteo RP, Fong Y : Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovoroin in patients with resected liver metastases from colorectal cancer. Ann Oncol 20: 1236-41, 2009.
  157. Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, Schwartz LH, Allen P, D'Angelica M, Fong Y, DeMatteo RP, Blumgart LH, Jarnagin WR: Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB 11: 445-51, 2009.
  158. Mezhir JJ, Brennan MF, Baser RE, D'Angelica MI, Fong Y, DeMatteo RP, Jarnagin WR, Allen PJ: A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified. J Gastrointest Surg 13: 2163-9, 2009.
  159. Miller G, Socci ND, Dhall D, D'Angelica M, DeMatteo RP, Allen PJ, Singh B, Fong Y, Blumgart LH, Klimstra DS, Jarnagin WR: Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract. J Exp Clin Cancer Res 28: 62, 2009.
  160. Sima CS, Jarnagin WR, Fong Y, Elkin E, Fischer M, Wuest D, D'Angelica M, DeMatteo RP, Blumgart LH, Gonen M.: Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg 250: 914-21, 2009.
  161. Auer RC, White RR, Kemeny NE, Schwartz LH, Shia J, Blumgart LH, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica MI: Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer 116: 1502-9, 2010.
  162. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, DeMatteo RP: Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51: 621-32, 2010.
  163. Bamboat ZM, Ocuin LM, Balachandran VP, Obaid H, Plitas G, DeMatteo RP: Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120: 559-69, 2010.
  164. Canter RJ, Patel SA, Kennedy T, D'Angelica MI, Jarnagin WR, Fong Y, Blumgart LH, Freeman RB, DeMatteo RP, Abt PL: Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the Milan criteria treated with liver transplantation versus partial hepatectomy.  Am J Clin Oncol 34: 466-71, 2010.
  165. Correa D, Schwartz L, Jarnagin WR, Tuorto S, DeMatteo RP, D'Angelica M, Allen P, Brown K, Fong Y: Kinetics of liver volume changes in the first year after portal vein embolization. Arch Surg 145: 351-4, 2010.
  166. Fischer M, Matsuo K, Gonen M, Grant F, DeMatteo RP, D'Angelica MI, Mascarenhas J, Brennan MF, Allen PJ, Blumgart LH, Jarnagin WR: Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: Results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. Ann Surg 252: 952-8, 2010.
  167. Hillman SL, Mandrekar SJ, Bot B, DeMatteo RP, Perez EA, Ballman KV, Nelson H, Buckner JC, Sargent DJ: Evaluation of the value of attribution in the interpretation of adverse event data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation. J Clin Oncol 28: 3002-7, 2010.
  168. House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR, D'Angelica MI: Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 210: 744-52, 752-5, 2010.
  169. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, Fong Y, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR: Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 251: 675-81, 2010.
  170. Jayaraman S, Gonen M, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Allen PJ: Laparoscopic distal pancreatectomy: Evolution of a technique at a single institution. J Am Coll Surg 211: 503-9, 2010.
  171. Katz SC, Donkor C, Glasgow K, Pillarisetty VG, Gönen M, Espat NJ, Klimstra DS, D'Angelica MI, Allen PJ, Jarnagin W, DeMatteo RP, Brennan MF, Tang LH: T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB 12: 674-83, 2010.
  172. Maithel SK, Ginsberg MS, D'Amico F, DeMatteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D'Angelica MI: Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. J Am Coll Surg 210: 31-8, 2010.
  173. Morris K, Tuorto S, Gonen M, Schwartz L, DeMatteo RP, D'Angelica Jarnagin WR, Fong Y: Simple measurement of intra-abdominal fat for abdominal surgery outcome prediction. Arch Surg 145: 1069-73, 2010.
  174. Ocuin LM, Bamboat ZM, Balachandran VP, Cavnar M, Obaid H, Plitas G, DeMatteo RP: Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J Leukoc Biol 89: 423-32, 2010.
  175. Park J, Pillarisetty VG, Brennan MF, Jarnagin WR, D'Angelica MI, DeMatteo RP, G Coit D, Janakos M, Allen PJ: Electronic synoptic operative reporting: Assessing the reliability and completeness of synoptic reports for pancreatic resection. J Am Coll Surg 211: 308-15, 2010.
  176. Balachandran VP, Cavnar MJ, Zeng S, Bamboat ZM, Ocuin LM, Obaid H, Sorenson EC, Popow R, Ariyan C, Rossi F, Besmer P, Guo T, Antonescu Cristina R, Taguchi T, Yuan J, Wolchok JD, Allison JP, DeMatteo RP: Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat Med 17: 1094-100, 2011.
  177. Bickenbach KA, Shia J, Klimstra DS, DeMatteo RP, Fong Y, Kingham TP, Allen PJ, Jarnagin WR, D'Angelica MI: High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. HPB 13: 865-8, 2011.
  178. Butte JM, Brennan MF, Gönen M, Tang LH, D'Angelica MI, Fong Y, DeMatteo RP, Jarnagin WR, Allen PJ: Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. J Gastrointest Surg 15: 350-7, 2011.
  179. Butte JM, Do RK, Shia J, Gönen M, D'Angelica MI, Getrajdman GI, Allen PJ, Fong Y, DeMatteo RP, Klimstra DS, Jarnagin WR: Liver angiomyolipomas: A clinical, radiologic, and pathologic analysis of 22 patients from a single center. Surgery 150: 557-67, 2011.
  180. Butte JM, Gönen M, Allen PJ, D'Angelica MI, Kingham TP, Fong Y, DeMatteo RP, Blumgart L, Jarnagin WR: The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB 13: 463-72, 2011.
  181. Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ, Fong Y, DeMatteo RP, Blumgart L, Endo I, De La Fuente H, Jarnagin WR: Gallbladder cancer: Differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg 212: 50-61, 2011.
  182. D'Angelica M, Ammori J, Gonen M, Klimstra DS, Low PS, Murphy L, Weiser MR, Paty Philip B, Fong Yuman, DeMatteo RP, Allen P, Jarnagin WR, Shia J: Folate receptor-α expression in resectable hepatic colorectal cancer metastases: Patterns and significance. Mod Pathol 24: 1221-8, 2011.
  183. D'Angelica M, Kornprat P, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol 18: 1096-103, 2011.
  184. Govindarajan A, Arnaoutakis D, D'Angelica M, Allen PJ, DeMatteo RP, Blumgart LH, Jarnagin WR, Fong Y: Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases. J Gastrointest Surg 15: 1168-72, 2011.
  185. House MG, Kemeny NE, Gönen M, Fong Y, Allen PJ, Paty PB, DeMatteo RP, Blumgart LH, Jarnagin WR, D'Angelica MI: Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Ann Surg 254: 851-6, 2011.
  186. Ito H, Ito K, D'Angelica M, Gonen M, Klimstra D, Allen P, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Accurate staging for gallbladder cancer: Implications for surgical therapy and pathological assessment. Ann Surg 254: 320-5, 2011.
  187. Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, Strong VE: Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): A size-matched comparison. Ann Surg Oncol 18: 1599-605, 2011.
  188. Katz SC, Ryan K, Ahmed N, PG, Chaudhry UI, Kingham TP, Naheed S, Nguyen C, Somasundar P, Espat NJ, Junghans RP, DeMatteo RP: Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J Immunol 187: 1150-6, 2011.
  189. Kemeny NE, Jarnagin WR, Capanu M, Fong Y, Gewirtz AN, DeMatteo RP, D'Angelica MI: Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol 29: 884-9, 2011.
  190. Learn PA, Grossman EB, Do RKG, Allen PJ, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Klimstra DS, Schattner MA, Jarnagin WR: Pitfalls in avoiding operation for autoimmune pancreatitis. Surgery 150: 968-74, 2011.
  191. Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ: Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol 18: 199-206, 2011.
  192. Yopp AC, Katabi N, Janakos M, Klimstra DS, D'Angelica MI, DeMatteo RP, Fong Y, Brennan MF, Jarnagin WR, Allen PJ: Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg 253: 968-74, 2011.
  193. Yopp AC, Schwartz LH, Kemeny N, Gultekin DH, Gönen M, Bamboat Z, Shia J, Haviland D, D'Angelica MI, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR: Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Ann Surg Oncol 18: 2192-9, 2011.
  194. Gaujoux S, Brennan MF, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Schattner M, DiMaio C, Janakos M, Jarnagin WR, Allen PJ.: Cystic lesions of the pancreas: Changes in the presentation and  management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg  212: 590-600, 201.
  195. Ammori JB, D'Angelica MI, Fong Y, Cercek A, DeMatteo RP, Allen PJ, Kingham TP, Paty PB, Jarnagin WR, Kemeny NE: Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease. J Surg Oncol 106: 953-8, 2012.
  196. Bickenbach KA, Gonen M, Tang LH, O'Reilly E, Goodman K, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Allen PJ: Downstaging in pancreatic cancer: A matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol 19: 1663-9, 2012.
  197. Butte JM, Gonen M, Ding P, Goodman KA, Allen PJ, Nash GM, Guillem J, Paty PB, Saltz LB, Kemeny NE, DeMatteo RP, Fong Y, Jarnagin WR, Weiser MR, D'Angelica MI: Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer 118: 5414-23, 2012.
  198. Chen J, Guo T, Zhang L, Qin LX, Singer S, Maki RG, Taguchi T, DeMatteo RP, Besmer P, Antonescu CR: CD133 and CD 44 are universally overexpressed in GIST and do not represent cancer stem cell markers. Genes Chromosomes Cancer 51: 186-95, 2012.
  199. Correa-Gallego C, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ: Contemporary experience with postpancreatectomy hemorrhage: Results of 1,122 patients resected between 2006 and 2011. J Am Coll Surg 215: 616-21, 2012.
  200. Gaujoux S, Al-Ahmadie H, Allen PJ, Gonen M, Shia J, D'Angelica M, DeMatteo RP, Fong Y, Blumgart L, Jarnagin WR: Resection of adrenocortical carcinoma liver metastasis: Is it justified?  Ann Surg Oncol 19: 2643-51, 2012.
  201. Gaujoux S, Tang L, Klimstra D, Gonen M, Brennan MF, D'Angelica M, DeMatteo RP, Fong Y, Jarnagin W, Allen PJ: The outcome of resected cystic pancreatic endocrine neoplasms: A case-matched analysis.  Surgery 4: 518-25, 2012.
  202. Gaujoux S, Torres J, Olson S, Winston C, Gonen M, Brennan MF, Klimstra DS, D'Angelica M, DeMatteo RP, Fong Y, House M, Jarnagin W, Kurtz RC, Allen PJ: Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.  Ann Surg Oncol 19: 2908-16, 2012.
  203. Italiano A, Chen CL, Sung YS, Singer S, DeMatteo RP, LaQuaglia MP, Besmer P, Socci N, Antonescu CR: SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors. BMC Cancer 12: 408, 2012.
  204. Italiano A, Chen J, Zhang L, Hajdu M, Singer S, DeMatteo RP, Antonescu CR: Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours. Euro J Cancer 48: 3215-22, 2012.
  205. Ito K, Ito H, Kemeny NE, Gonen M, Allen PJ, Paty PB, Fong Y, DeMatteo RP, Blumgart LH, Jarnagin William R, D'Angelica MI: Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: Incidence, clinical features, and risk factors. Ann Surg Oncol 19: 1609-17, 2012.
  206. Kingham TP, Karkar AM, D'Angelica MI, Allen PJ, DeMatteo RP, Getrajdman GI, Sofocleous CT, Solomon SB, Jarnagin WR, Fong Y: Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 215: 379-87, 2012.
  207. Lyons JM, Karkar A, Correa-Gallego CC, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Brennan MF, Allen PJ: Operative procedures for unresectable pancreatic cancer: Does operative bypass decrease requirements for postoperative procedures and in-hospital days? HPB 14: 469-75, 2012.
  208. Maithel SK, Gönen M, Ito H, DeMatteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D'Angelica MI: Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery 151: 162-70, 2012.
  209. Maker AV, Butte  JM, Oxenberg J, Kuk D, Gonen M, Fong Y, DeMatteo RP, D'Angelica MI, Allen PJ, Jarnagin WR: Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol 19: 409-17, 2012.
  210. Matsuo K, Rocha FG, Ito K, D'Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Gonen M, Endo I, Jarnagin WR: The Blumgart preoperative staging system for hilar cholangiocarcinoma: Analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215: 343-55, 2012.
  211. McCarter MD, Antonescu CR, Ballman KV, Maki RG, Pisters PWT, Demetri GD, Blanke CD, von Mehren M, Brennan MF, McCall L, Ota DM, DeMatteo RP: Microscopically positive margins for primary gastrointestinal stromal tumors: Analysis of risk factors and tumor recurrence. J Am Coll Surg 215: 53-9, 2012.
  212. Ocuin LM, Zeng S, Cavnar MJ, Sorenson EC, Bamboat ZM, Greer JB, Kim TS, Popow R, DeMatteo RP: Nilotinib protects the murine liver from ischemia/reperfusion injury. J Hepatol 57: 766-73, 2012.
  213. Poultsides GA, Bao F, Servais EL, Hernandez-Boussard T, DeMatteo RP, Allen PJ, Fong Y, Kemeny NE, Saltz LB, Klimstra DS, Jarnagin WR, Shia J, D'Angelica MI: Pathologic response to preoperative chemotherapy in colorectal liver metastases: Fibrosis, not necrosis, predicts outcome. Ann Surg Oncol 19: 2797-804, 2012.
  214. Poultsides GA, Bao F, Servais EL, Hernandez-Boussard T, DeMatteo RP, Allen PJ, Fong Y, Kemeny NE, Saltz LB, Klimstra DS, Jarnagin WR, Shia J, D'Angelica MI : Pathologic response to preoperative chemotherapy in colorectal liver metastases: Fibrosis, not necrosis, predicts outcome.  Ann Surg Oncol 19: 2797-804, 2012.
  215. Sofocleous CT, Garg S, Petrovic LM, Gonen M, Petre EN, Klimstra DS, Solomon SB, Brown KT, Brody LA, Covey AM, DeMatteo RP, Schwartz L, Kemeny NE: Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol 19: 4262-9, 2012.
  216. Winter JM, Brennan MF, Tang LH, D'Angelica MI, DeMatteo RP, Fong Y, Klimstra DS, Jarnagin WR, Allen PJ: Survival after resection of pancreatic adenocarcinoma: Results from a single institution over three decades. Ann Surg Oncol 19: 169-75, 2012.
  217. Winter JM, Tang LH, Klimstra DS, Brennan MF, Brody JR, Rocha FG, Jia X, Qin LX, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, O'Reilly EM, Allen PJ: A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PLoS one 7(7): e40157, 2012.
  218. Yopp AC, Shia J, Butte JM, Allen PJ, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI: CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Ann Surg Oncol 19 Suppl 3: S339-46, 2012.
  219. Zeng S, Zhang QY, Huang J, Vedantham S, Rosario R, Ananthakrishnan R, Yan SF, Ramasamy R, DeMatteo RP, Emond JC, Friedman RA, Schmidt AM: Opposing roles of RAGE and Myd88 signaling in extensive liver resection. FASEB J 26: 882-93, 2012.
  220. Ammori JB, Kemeny NE, Fong Y, Cercek A, DeMatteo RP, Allen PJ, Kingham TP, Gonen M, Paty PB, Jarnagin WR, D'Angelica MI: Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: A decade of experience at a single institution. Ann Surg Oncol 20: 2901-7, 2013.
  221. Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, DeMatteo RP, Venook AP, Abou-Alfa GK: Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: Data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res 6: 3-9, 2013.
  222. Ang CSP, Sun MY, Huitzil-Melendez DF, Chou JFL, Capanu M, Jarnagin W, Fong Y, DeMatteo RP, D'Angelica M, Allen P, Chen CT, O'Reilly EM, Weiser MR, Abou-Alfa GK: c-MET and HGF mRNA expression in hepatocellular carcinoma: Correlation with clinicopathological features and survival. Anticancer Res 33: 3241-5, 2013.
  223. Araujo R, Gonen M, Allen P, Blumgart L, DeMatteo RP, Fong Y, Kemeny N, Jarnagin W, D'Angelica M: Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.  Ann Surg Oncol 20: 4312-21, 2013.
  224. Araujo RLC, Gaujoux S, Huguet Flor, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Goodman KA, Allen PJ: Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. HPB 15: 574-80, 2013.
  225. Bickenbach KA, DeMatteo RP, Fong Y, Peter KT, Allen PJ, Jarnagin WR, D'Angelica MI: Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: A contemporary analysis. Ann Surg Oncol 20: 2029-34, 2013.
  226. Butte JM, Torres J, Veras EF, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Meneses M, Inayama Y, Fong Y, DeMatteo RP, De La Fuente H, Endo I, Klimstra DS, Jarnagin WR: Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression. Ann Surg Oncol 20: 1470-81, 2013.
  227. Cavell LK, Allen PJ, Vinoya C, Eaton AA, Gonen M, Gerdes H, Mendelsohn RB, D'Angelica MI, Kingham TP, Fong Y, DeMatteo RP, Jarnagin WR, Kurtz RC, Schattner MA: Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy. Am J Gastroenterol 108: 1168-73, 2013.
  228. Cavnar MJ, Zeng S, Kim TS, Sorenson EC, Ocuin LM, Balachandran VP, Seifert AM, Greer JB, Popow R, Crawley MH, Cohen NA, Green BL, Rossi F, Besmer P, Antonescu CR, DeMatteo RP: KIT oncogene inhibition drives intratumoral macrophage M2 polarization.  J Exp Med 210: 2873-86, 2013.
  229. Cercek A, D'Angelica M, Power D, Capanu M, Gewirtz A, Patel D, Allen P, Fong Y, DeMatteo RP, Jarnagin WR, Kemeny NE: Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.  Ann Surg Oncol 21: 479-86, 2013.
  230. Correa-Gallego C, Brennan MF, DʼAngelica M, Fong Y, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ: Operative drainage following pancreatic resection: Analysis of 1122 patients resected over 5 years at a single institution. Ann Surg 258: 1051-8, 2013.
  231. Correa-Gallego C, Do R, LJ, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ: Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: Development of a preoperative nomogram. Ann Surg Oncol 20: 4348-55, 2013.
  232. Correa-Gallego C, Gonen M, Fischer M, Grant F, Kemeny N E, Arslan-Carlon V, Kingham TP, DeMatteo RP, Fong Y, Allen PJ, D'Angelica MI, Jarnagin WR.: Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. Ann Surg Oncol 20: 2477-84, 2013.
  233. D'Amico FE, Allen PJ, Eaton AA, DeMatteo RP, Fong Y, Kingham TP, Blumgart LH, Jarnagin WR, D'Angelica MI: Vascular inflow control during hemi-hepatectomy: A comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. HPB 15: 449-56, 2013.
  234. DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PWT, Demetri GD, Brennan MF, Owzar K: Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Ann Surg 258: 422-9, 2013.
  235. Fischer C, Melstrom LG, Arnaoutakis D, Jarnagin W, Brown K, D'Angelica M, Covey A, DeMatteo RP, Allen P, Kingham TP, Tuorto S, Kemeny N, Fong Y. : Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy.  JAMA Surg  148: 1103-8, 2013.
  236. Frankel TL, Fischer M, Grant F, Krone J, D'Angelica MI, DeMatteo RP, Jarnagin WR, Gönen M: Selecting patients for acute normovolemic hemodilution during hepatic resection: A prospective randomized evaluation of nomogram-based allocation. J Am Coll Surg 217: 210-20, 2013.
  237. Frankel TL, LaFemina J, Bamboat ZM, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ: Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB 15: 814-21, 2013.
  238. Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica M: Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. PLoS one 8(12): e81680, 2013.
  239. Karanicolas PJ, Jarnagin WR, Gonen M, Tuorto S, Allen PJ, DeMatteo RP, D'Angelica MI, Fong Y: Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg 148: 597-601, 2013.
  240. Karkar AM, Tang LH, Kashikar ND, Gonen M, Solomon SB, Dematteo RP, D' Angelica MI, Correa-Gallego C, Jarnagin WR, Fong Y, Getrajdman GI, Allen P, Kingham TP: Management of hepatocellular adenoma: Comparison of resection, embolization and observation. HPB 15: 235-43, 2013.
  241. Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat Cyrus V, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP: Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol 20: 946-55, 2013.
  242. Kelly KJ, Dukleska K, Kuk D, Kingham TP, D'Angelica MI, DeMatteo RP, Allen PJ, Jarnagin WR, FongY. : Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Ann Surg Oncol 21: 979-85, 2013.
  243. Konstantinidis IT, Allen PJ, D'Angelica MI, DeMatteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.: Pancreas and liver resection in Jehovah's witness patients: Feasible and safe.  J Am Coll Surg 217: 1101-7, 2013.
  244. Konstantinidis IT, Vinuela EF, Tang LH, Klimstra DS, D'Angelica MI, DeMatteo RP, Kingham TP, Fong Y, Jarnagin WR, Allen PJ: Incidentally discovered pancreatic intraepithelial neoplasia: What is its clinical significance? Ann Surg Oncol 20: 3643-7, 2013.
  245. LaFemina J, Chou JF, Gönen M, Rocha FG, Correa-Gallego C, Kingham TP, Fong Y, D'Angelica MI, Jarnagin WR, DeMatteo RP, Allen PJ: Hepatic arterial nodal metastases in pancreatic cancer: Is this the node of importance? J Gastrointest Surg 17: 1092-7, 2013.
  246. Lafemina J, Katabi N, Klimstra D, Correa-Gallego C, Gaujoux S, Kingham T P, DeMatteo RP, Fong Y, D'Angelica MI, Jarnagin WR, Do RK, Brennan MF, Allen PJ: Malignant progression in IPMN: A cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol 20: 440-7, 2013.
  247. Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR: Changes in the management of benign liver tumors: An analysis of 285 patients. HPB 15: 156-63, 2013.
  248. O'Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo RP, Engel LS: Gastrointestinal stromal tumors: A case-only analysis of single nucleotide polymorphisms and somatic mutations.  Clin Sarcoma Res 3: 12, 2013.
  249. Perez DR, Baser RE, Cavnar MJ, Balachandran VP, Antonescu CR, Tap WD, Strong VE, Brennan MF, Coit DG, Singer S, DeMatteo RP: Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol 20: 593-9, 2013.
  250. Tan MCB, Butte JM, Gonen M, Kemeny N, Fong Y, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, D'Angelica MI: Prognostic significance of early recurrence: A conditional survival analysis in patients with resected colorectal liver metastasis. HPB 15: 803-13, 2013.
  251. Weiss MJ, Ito H, Araujo RL C, Zabor EC, Gonen M, D'Angelica MI, Allen PJ, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR: Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: No impact on survival or hepatic recurrence. Ann Surg Oncol 20: 285-94, 2013.
  252. Winter JM, Tang LH, Klimstra DS, Liu W, Linkov I, Brennan MF, DÊ Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, OʼReilly EM, Allen PJ: Failure patterns in resected pancreas adenocarcinoma: Lack of predicted benefit to SMAD4 expression. Ann Surg 258: 331-5, 2013.
  253. Wolf PS, Park JO, Bao Fei, Allen PJ, DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N, Shia J, D'Angelica MI: Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: A single institution experience. J Am Coll Surg 216: 41-9, 2013.
  254. Allen PJ, Gönen M, Brennan MF, Bucknor AA, Robinson LM, Pappas MM, Carlucci KE, D'Angelica MI, DeMatteo RP, Kingham TP, Fong Y, Jarnagin WR: Pasireotide for postoperative pancreatic fistula. N Engl J Med 370: 2014-22, 2014.
  255. Ammori JB, Do RKG, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Allen PJ: Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: A radiographic finding with potentially increased malignant potential. J Gastrointest Surg 18: 911-6, 2014.
  256. Araujo RLC, Karkar AM, Allen PJ, Gönen M, Chou JF, Brennan MF, Blumgart LH, D'Angelica MI, DeMatteo RP, Coit DG, Fong Y, Jarnagin WR: Timing of elective surgery as a perioperative outcome variable: Analysis of pancreaticoduodenectomy. HPB 16: 250-62, 2014.
  257. Butte JM, Kingham TP, Gönen M, D'Angelica MI, Allen PJ, Fong Yuman, DeMatteo RP, Jarnagin WR: Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg 219: 416-29, 2014.
  258. Cardona K, Donataccio D, Kingham TP, Allen PJ, DeMatteo RP, Fong Y, Jarnagin WR, Cercek A, Kemeny NE, D'Angelica MI: Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: The role of salvage therapy for recurrent disease. Ann Surg Oncol 21: 815-21, 2014.
  259. Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PWT, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP: Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: The ACOSOG Z9001 trial. J Clin Oncol 32: 1563-70, 2014.
  260. Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, Fisher S, Viñuela EF, Kingham TP, Fong Y, DeMatteo RP, D'Angelica MI, Jarnagin WR, Allen PJ: Minimally-invasive vs open pancreaticoduodenectomy: Systematic review and meta-analysis. J Am Coll Surg 218: 129-39, 2014.
  261. Correa-Gallego C, Fong Y, Gonen M, D'Angelica MI, Allen PJ, DeMatteo RP, Jarnagin WR, Kingham TP: A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol 21: 4278-83, 2014.
  262. Do RKG, McErlean A, Ang CS, DeMatteo RP, Abou-Alfa GK: CT and MRI of primary and metastatic fibrolamellar carcinoma: A case series of 37 patients. Br J Radiol 87: 20140024, 2014.
  263. Evrard S, Poston G, Kissmeyer-Nielsen P, Diallo A, Desolneux G, Brouste V, Lalet C, Mortensen F, Stättner S, Fenwick S, Malik H, Konstantinidis I, DeMatteo RP, D'Angelica M, Allen P, Jarnagin W, Mathoulin-Pelissier S, Fong Y: Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One 9: e114404, 2014.
  264. Joensuu H, Eriksson M, Hall Kirsten S, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran Salah-Eddin, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman Karla V, Leinonen M, DeMatteo RP, Reichardt P: Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib. Cancer 120: 2325-33, 2014.
  265. Katabi N, Pillarisetty VG, DeMatteo RP, Klimstra DS: Choledochal cysts: A clinicopathologic study of 36 cases with emphasis on the morphologic and the immunohistochemical features of premalignant and malignant alterations.  Human Pathol 45: 2107-14, 2014.
  266. 266. Kemeny NE, Chou JF, Capanu M, Gewirtz AN, Cercek A, Kingham TP, Jarnagin WR, Fong YC, DeMatteo RP, Allen PJ, Shia J, Ang C, Vakiani E, D'Angelica MI: KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Cancer 120: 3965-71, 2014.
  267. Kim TS, Cavnar MJ, Cohen NA, Sorenson EC, Greer JB, Seifert AM, Crawley MH, Green BL, Popow R, Pillarsetty N, Veach DR, Ku AT, Rossi F, Besmer P, Antonescu CR, Zeng S, DeMatteo RP: Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor. Clin Cancer Res 20: 2350-62, 2014.
  268. Koerkamp BG, Wiggers JK, Allen PJ, Busch OR, D'Angelica MI, DeMatteo RP, Fong Y, Gonen M, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR : American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: A comparison of the 6th and 7th editions. HPB 16: 1074-82, 2014.
  269. Konstantinidis IT, Do RKG, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR: Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: A potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol 21: 2675-83, 2014.
  270. Lee SY, Konstantinidis IT, Eaton AA, Gönen M, Kingham TP, D'Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR: Predicting recurrence patterns after resection of hepatocellular carcinoma.  HPB 16: 943-53, 2014.
  271. Leung U, Pandit-Taskar N, Corvera CU, D'Angelica MI, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, Fong Y: Impact of pre-operative positron emission tomography in gallbladder cancer.  HPB 16: 1023-30, 2014.
  272. Leung U, Simpson AL, Araujo RLC, Gönen M, McAuliffe C, Miga MI, Parada EP, Allen PJ, D'Angelica MI, Kingham TP, DeMatteo RP, Fong Y, Jarnagin WR: Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg 219: 620-30, 2014.
  273. Nathan H, Weiss MJ, Soff GA, Stempel M, DeMatteo RP, Allen PJ, Kingham TP, Fong Y, Jarnagin WR, D'Angelica MI: Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. J Gastrointest Surg 18: 295-302, 2014.
  274. O'Reilly EM, Perelshteyn A, Jarnagin WR, Schattner M, Gerdes H, Capanu M, Tang LH, LaValle J, Winston C, DeMatteo RP, DʼAngelica M, Kurtz RC, Abou-Alfa GK, Klimstra DS, Lowery MA, Brennan MF, Coit DG, Reidy DL, Kingham TP, Allen PJ: A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. Ann Surg 260: 142-8, 2014.
  275. Patwardhan PP, Surriga O, Beckman MJ, de Stanchina E, DeMatteo RP, Tap WD, Schwartz GK: Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs. Clin Cancer Res 20: 3146-58, 2014.
  276. Sadot E, Brennan MF, Lee SY, Allen PJ, Gönen M, Groeger JS, Peter KT, D'Angelica MI, DeMatteo RP, Jarnagin WR, Fong Y: Readmission after pancreatic resection: Causes and causality pattern. Ann Surg Oncol 21: 4342-50, 2014.
  277. Tilara A, Gerdes H, Allen P, Jarnagin W, Kingham P, Fong Y, DeMatteo RP, D'Angelica M, Schattner M: Endoscopic ultrasound-guided transmural drainage of postoperative pancreatic collections.  J Am Coll Surg 218: 33-40, 2014.
  278. Turcotte S, Katz SC, Shia J, Jarnagin WR, Kingham TP, Allen PJ, Fong Y, D'Angelica MI, DeMatteo RP: Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. Cancer Immunol Res 2: 530-7, 2014.
  279. Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Tang LH: Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg 18: 457-62, 2014.
  280. Araujo RL, Gönen M, Allen P, DeMatteo RP, Kingham P, Jarnagin W, D'Angelica M, Fong Y: Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.  Ann Surg Oncol 22: 3087-93, 2015.
  281. Burga RA, Thorn M, Point GR, Guha P, Nguyen CT, Licata LA, DeMatteo RP, Ayala A, Joseph EN, Junghans RP, Katz SC: Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunol Immunother 64: 817-29, 2015.
  282. Butte JM, Gönen M, Allen PJ, Peter KT, Sofocleous CT, DeMatteo RP, Fong Y, Kemeny NE, Jarnagin WR, D'Angelica MI: Recurrence after partial hepatectomy for metastatic colorectal cancer: Potentially curative role of salvage repeat resection. Ann Surg Oncol 22: 2761-71, 2015.
  283. Chapman WC, Klintmalm G, Hemming A, Vachharajani N, Majella Doyle MB, DeMatteo RP, Zaydfudim V, Chung H, Cavaness K, Goldstein R, Zendajas I, Melstrom LG, Nagorney D, Jarnagin W: Surgical treatment of hepatocellular carcinoma in North America: Can hepatic resection still be justified?  J Am Coll Surg 220: 628-37, 2015.
  284. Cohen NA, Zeng S, Seifert AM, Kim TS, Sorenson EC, Greer JB, Beckman MJ, Santamaria-Barria JA, Crawley MH, Green BL, Rossi F, Besmer P, Antonescu CR, DeMatteo RP: Pharmacological inhibition of KIT activates MET signaling in gastrointestinal stromal tumors. Cancer Res 75: 2061-70, 2015.
  285. Correa-Gallego C, Berman A, Denis SC, Langdon-Embry L, O'Connor D, Arslan-Carlon V, Kingham TP, D'Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR, Melendez J, Fischer M: Renal function after low central venous pressure-assisted liver resection: Assessment of 2116 cases.  HPB 17: 258-64, 2015.
  286. Correa-Gallego C, Gavane S, Grewal R, Cercek A, Klimstra DS, Gewirtz AN, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N, D'Angelica MI.: Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. HPB 17: 644-50, 2015.
  287. Correa-Gallego C, Tan KS, Arslan-Carlon V, Gonen M, Denis SC, Langdon-Embry L, Grant F, Kingham TP, DeMatteo RP, Allen PJ, D'Angelica Michael I, Jarnagin WR, Fischer M.: Goal-Directed fluid therapy using stroke volume variation for resuscitation after low central venous pressure-assisted liver resection: A randomized clinical trial. J Am Coll Surg 221: 591-601, 2015.
  288. D'Angelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N: Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes. Ann Surg 261: 353-60, 2015.
  289. Darcy DG, Malek MM, Kobos R, Klimstra DS, DeMatteo RP, La Quaglia MP: Prognostic factors in fibrolamellar hepatocellular carcinoma in young people.  J Pediatr Surg 50: 153-6, 2015.
  290. Doussot A, Groot-Koerkamp B, Wiggers JK, Chou J, Gonen M, DeMatteo RP, Allen PJ, Kingham TP, D'Angelica MI, Jarnagin WR.: Outcomes after resection of intrahepatic cholangiocarcinoma: External validation and comparison of prognostic models. J Am Coll Surg 221: 452-61, 2015.
  291. Groot KB, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch ORC, Coelen RJ, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Jarnagin WR, van Gulik TM: Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg 221: 1041-9, 2015.
  292. Hechtman JF, DeMatteo RP, Nafa K, Chi P, Arcila ME, Dogan S, Oultache A, Chen W, Hameed M. : Additional primary malignancies in patients with gastrointestinal stromal tumor (GIST): A clinicopathologic study of 260 patients with molecular analysis and review of the literature.  Ann Surg Oncol 22: 2633-9, 2015.
  293. Herbert GS, Prussing KB, Simpson AL, D'Angelica MI, Allen PJ, DeMatteo RP, Jarnagin WR, Kingham TP: Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. HPB 17: 1058-65, 2015.
  294. Kingham TP, Correa-Gallego C, D'Angelica MI, Gönen Mithat, DeMatteo RP, Fong Y, Allen PJ, Blumgart LH, Jarnagin WR: Hepatic parenchymal preservation surgery: Decreasing morbidity and mortality rates in 4,152 resections for malignancy. J Am Coll Surg 220: 471-9, 2015.
  295. Leal JN, Gonen M, Covey AM, Erinjeri JP, Getrajdman G, Sofocleous CT, D'Angelica M, DeMatteo RP, Abou-Alfa GK, Jarnagin WR, Fong Y, Brown KT: Locoregional therapy for hepatocellular carcinoma with and without extrahepatic spread. J Vasc and Interv Radiol 26: 1112-21, 2015.
  296. Leal JN, Kingham TP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kalin MF, Allen PJ: Intraductal papillary mucinous neoplasms and the risk of diabetes mellitus in patients undergoing resection versus observation. J Gastrointest Surg 19: 1974-81, 2015.
  297. Lee SY, Allen PJ, Sadot E, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP: Distal pancreatectomy: A single institution's experience in open, laparoscopic, and robotic approaches.  J Am Coll Surg 220: 18-27, 2015.
  298. Lee SY, Sadot E, Chou JF, Gönen M, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI: Central hepatectomy versus extended hepatectomy for liver malignancy: A matched cohort comparison. HPB 17: 1025-32, 2015.
  299. Leung U, Kuk D, D'Angelica MI, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Fong Y: Long-term outcomes following microwave ablation for liver malignancies. Br J Surg 102: 85-91, 2015.
  300. Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI: Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res 3: 380-8, 2015.
  301. Sadot E, Basturk O, Klimstra DS, Gönen M, Lokshin A, Do Richard KG, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ: Tumor-associated neutrophils and malignant progression in intraductal papillary mucinous neoplasms: An opportunity for identification of high-risk disease. Ann Surg 262: 1102-7, 2015.
  302. Sadot E, Doussot A, O'Reilly EM, Lowery MA, Goodman KA, Do RKG, Tang LH, Gönen M, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ: FOLFIRINOX induction therapy for stage 3 pancreatic adenocarcinoma. Ann Surg Oncol 22: 3512-21, 2015.
  303. Sadot E, Groot KB, Leal JN, Shia J, Gonen M, Allen PJ, DeMatteo RP, Kingham TP, Kemeny N, Blumgart LH, Jarnagin WR, DʼAngelica MI: Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: Surgical technique or biologic surrogate? Ann Surg 262: 476-85, 2015.
  304. Sadot E, Simpson AL, Do  RKG, Gonen M, Shia J, Allen PJ, D'Angelica Michael I, DeMatteo RP, Kingham TP, Jarnagin WR: Cholangiocarcinoma: Correlation between molecular profiling and imaging phenotypes. PLoS One 10(7): e0132953, 2015.
  305. Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gönen M, D'Angelica MI, Kingham TP, Jarnagin WR, DeMatteo RP: Clinical features and outcome of primary pancreatic lymphoma.  Ann Surg Oncol 22: 1176-84, 2015.
  306. Samdani RT, Hechtman JF, O'Reilly E, DeMatteo RP, Sigel CS: EBV-associated lymphoepithelioma-like carcinoma of the pancreas: Case report with targeted sequencing analysis.  Pancreatology 15: 302-4, 2015.
  307. Silberhumer GR, Paty PB, Temple LK, Araujo RLC, Denton B, Gonen M, Nash GM, Allen PJ, DeMatteo RP, Guillem J, Weiser MR, D'Angelica MI, Jarnagin WR, Wong DW, Fong Y: Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 209: 935-42, 2015.
  308. Simpson AL, Adams LB, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Leung Universe, Miga Michael I, Parada EP, Jarnagin WR, Do RKG: Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: A preliminary study. J Am Coll Surg 220: 339-46, 2015.
  309. Simpson AL, Leal JN, Pugalenthi A, Allen PJ, DeMatteo RP, Fong Y, Gönen M, Jarnagin WR, Kingham TP, Miga MI, Shia J, Weiser MR, D'Angelica MI: Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. J Am Coll Surg 220: 271-80, 2015.
  310. Strong VE, Selby LV, Sovel M, Disa JJ, Hoskins W, DeMatteo RP, Scardino P, Jaques DP : Development and assessment of Memorial Sloan Kettering Cancer Center's surgical secondary events grading system. Ann Surg Oncol 22: 1061-7, 2015.
  311. Tamandl D, Butte JM, Allen PJ, D'Angelica MI, DeMatteo RP, Groeger JS, Jarnagin WR, Fong Y: Hospital readmissions after liver surgery for metastatic colorectal cancer. Surgery 157: 231-8, 2015.
  312. Wiggers JK, Groot KB, Coelen RJ, Doussot A, van Dieren S, Rauws EA, Schattner MA, van Lienden KP, Brown KT, Besselink MG, van Tienhoven G, Allen PJ, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Verheij J, Jarnagin WR, van Gulik TM: Percutaneous preoperative biliary drainage for resectable perihilar Cholangiocarcinoma: No association with survival and no increase in seeding metastases. Ann Surg Oncol 22 Suppl 3: S1156-63, 2015.
  313. Wiggers JK, Koerkamp BG, Coelen RJ, Rauws EA, Schattner MA, Nio CY, Brown KT, Gonen M, van Dieren S, van Lienden KP, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Jarnagin WR, van Gulik TM: Preoperative biliary drainage in perihilar cholangiocarcinoma: Identifying patients who require percutaneous drainage after failed endoscopic drainage. Endoscopy 47: 1124-31, 2015.
  314. Aufhauser DD, Sadot E, Murken DR, Eddinger K, Furth EE, Hoteit M, Abt PL, Goldberg DS, DeMatteo RP, Levine MH: Occult intrahepatic metastasis in hepatocellular carcinoma treated with transplantation or partial hepatectomy.  Ann Surg 2016.
  315. Balachandran VP, Arora A, Gönen M, Ito H, Turcotte S, Shia J, Viale A, Snoeren N, van Hooff SR, Rinkes IHMB, Adam René, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI: A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases. Clin Cancer Res 22: 2575-82, 2016.
  316. Brown KT, Do RK, Gonen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson KN, Garcia AR, Beattie C, Zhao B, Solomon SB, Schwartz LH, DeMatteo RP, Abou-Alfa GK: Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone.  J Clin Oncol 34: 2046-53, 2016.
  317. Correa-Gallego C, Maddalo D, Doussot A, Kemeny N, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Betel D, Klimstra D, Jarnagin WR, Ventura A: Circulating plasma levels of MicroRNA-21 and MicroRNA-221 are potential diagnostic markers for primary intrahepatic cholangiocarcinoma. PLoS One 11(9): e0163699, 2016.
  318. D'Angelo SP, Shoushtari AN, Keohan ML, Dickson MA, Gounder MM, Chi P, Loo JK, Gaffney L, Schneider L, Patel Z, Erinjeri JP, Bluth MJ, SA, Streicher H, Takebe N, Qin LX, Antonescu C, DeMatteo RP, Carvajal RD, Tap WD.: Combined KIT and CTLA-4 A Phase Ib study of dasatinib plus ipilimumab. Clin Cancer Res 2016.
  319. Dominguez-Rosado I, Moutinho V, DeMatteo RP, Kingham TP, D'Angelica M, Brennan MF: Outcomes of the Memorial Sloan Kettering Cancer Center International general surgical oncology fellowship. J Am Coll Surg 222: 961-6, 2016.
  320. Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, Fuks D, Allen PJ, Farges O, Kingham TP, Regimbeau JM, D'Angelica MI, Azoulay D, Jarnagin WR : Recurrence patterns and disease- free survival after resection of intrahepatic cholangiocarcinoma: Preoperative and postoperative prognostic models. J Am Coll Surg 223: 493-505, 2016.
  321. Eaton AA, Gonen M, Karanicolas P, Jarnagin WR, D'Angelica MI, DeMatteo RP, Kingham TP, Allen PJ : Health-related quality of life after pancreatectomy: Results from a randomized controlled trial. Ann Surg Oncol 23: 2137-45, 2016.
  322. Grant F, Brennan MF, Allen PJ, DeMatteo RP, Kingham TP, D'Angelica M, Fischer ME, Gonen M, Zhang H, Jarnagin WR: Prospective randomized controlled trial of liberal vs restricted perioperative fluid management in patients undergoing pancreatectomy. Ann Surg 264: 591-8, 2016.
  323. Groot KB, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MGH, Blumgart LH, Busch ORC, D'Angelica M I, DeMatteo RP, Gouma DJ, Kingham T P, van Gulik TM, Jarnagin WR: Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol 27: 753, 2016.
  324. Kemeny NE, Chou JF, Boucher TM, CM, DeMatteo RP, Jarnagin WR, Allen PJ, Fong YC, Cercek A, D'Angelica MI: Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. J Surg Oncol 113: 477-84, 2016.
  325. Kingham TP, Leung U, Kuk D, Gönen M, D'Angelica MI, Allen PJ, DeMatteo RP, Laudone VP, Jarnagin WR, Fong Y: Robotic liver resection: A case-matched comparison. World J Surg 40: 1422-8, 2016.
  326. Konstantinidis IT, Groot KB, Do RKG, Gönen M, Fong Y, Allen PJ, D'Angelica MI, Kingham TP, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR: Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Cancer 122: 758-65, 2016.
  327. Konstantinidis IT, Mastrodomenico P, Sofocleous CT, Brown KT, Getrajdman GI, Gönen M, Allen PJ, Kingham TP, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica MI: Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era. J Gastrointest Surg 20: 748-56, 2016.
  328. Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D'Angelica MI, Allen PJ, DeMatteo RP, Doyle MBM, Bathe OF, Greig PD, Wei A, Chapman WC, Dixon E, Jarnagin WR: Time-to-surgery and survival outcomes in resectable colorectal liver metastases: A Multi-Institutional evaluation. J Am Coll Surg 222: 766-79, 2016.
  329. Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica Michael ID, DeMatteo Ronald P, Fong Yuman, Jarnagin William R, Allen Peter J: Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol 113: 188-93, 2016.
  330. Rose JB, Correa-Gallego C, Li Y, Nelson J, Alseidi A, Helton WS, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Kowdley KV, Jarnagin WR, Rocha FG: The role of biliary carcinoembryonic antigen-related cellular adhesion molecule 6 (CEACAM6) as a biomarker in cholangiocarcinoma. PLoS One 11(3): e0150195, 2016.
  331. Sadot E, Lee SY, Sofocleous CT, Solomon SB, Gönen M, Peter KT, Allen PJ, DeMatteo RP, Jarnagin WR, Hudis CA, D'Angelica MI: Hepatic resection or ablation for isolated breast cancer liver metastasis: A Case-control study with comparison to medically treated patients. Ann Surg 264: 147-54, 2016.
  332. Sadot E, Reidy-Lagunes DL, Tang LH, Do Richard KG, Gonen M, D'Angelica MI, DeMatteo RP, Kingham TP, Groot KB, Untch BR, Brennan MF, Jarnagin WR, Allen PJ.: Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. Ann Surg Oncol 23: 1361-70, 2016.
  333. Seifert AM, Zeng S, Zhang JQ, Kim TS, Cohen NA, Beckman MJ, Medina BD, Maltbaek JH, Loo JK, Crawley MH, Rossi F, Besmer P, Antonescu CR, DeMatteo RP: PD-1/PD-L1 Blockade Enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors. Clin Cancer Res Page: epub, 2016.
  334. Silberhumer GR, Paty PB, Denton B, Guillem J, Gonen M, Araujo RLC, Nash GM, Temple LK, Allen PJ, DeMatteo RP, Weiser MR, Wong WD, Jarnagin WR, D'Angelica MI, Fong Y: Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. Surgery 160: 67-73, 2016.
  335. Sotirchos VS, Petrovic LM, Gönen M, Klimstra DS, Do RKG, Petre EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-Todorova KO, Sofocleous CT: Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome. Radiology 280: 949-59, 2016.
  336. Wang SC, Parekh JR, Porembka MR, Nathan H, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ: A pilot study evaluating serum MMP7 as a preoperative prognostic marker for pancreatic ductal adenocarcinoma patients. J Gastrointest Surg 20: 899-904, 2016.
  337. Wiggers JK, Groot KB, Cieslak KP, Doussot A, van Klaveren D, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR: Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg 223: 321-331.e1, 2016.
  338. Aufhauser DD, Sadot E, Murken DR, Eddinger K, Hoteit M, Abt PL, Goldberg DS, DeMatteo RP, Levine MH: Incidence of occult intrahepatic metastasis in hepatocellular carcinoma treated with transplantation corresponds to early recurrence rates after partial hepatectomy. Ann Surg 2017.
  339. Cavnar MJ, Turcotte S, Katz SC, Kuk D, Gönen M, Shia J, Allen PJ, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, DeMatteo RP: Tumor-Associated macrophage infiltration in colorectal cancer liver metastases is associated with better outcome. Ann Surg Oncol 2017.
  340. Fairweather M, Balachandran VP, Li GZ, Bertagnolli MM, Antonescu C, Tap W, Singer S, DeMatteo RP, Raut CP: Cytoreductive surgery for metastatic gastrointestinal stromal tumors treated with tyrosine kinase inhibitor therapy: A multicenter analysis, Ann Surg Page: epub, 2017.
  341. Frankel TL, Vakiani E, Nathan H, DeMatteo RP, Kingham TP, Allen PJ, Jarnagin WR, Kemeny NE, Solit DB, D'Angelica MI: Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases. Cancer 123: 568-575, 2017.
  342. Leal JN, Sadot E, Gonen M, Lichtman S, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI: Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: A contemporary case matched series. HPB 19: 162-169, 2017.
  343. Lee SY, Goh BKP, Sadot E, Rajeev R, Balachandran VP, Gönen M, Kingham TP, Allen PJ, D'Angelica MI, Jarnagin WR, Coit D, Wong WK, Ong HS, Chung AYF, DeMatteo RP: Surgical strategy and outcomes in duodenal gastrointestinal stromal tumor. Ann Surg Oncol 24: 202-210, 2017.
  344. Leung U, Gönen M, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, D'Angelica MI: Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection. Ann Surg 265: 158-165, 2017.
  345. Ma LW, Dominguez-Rosado I, Gennarelli RL, Bach PB, Gonen M, D'Angelica MI, DeMatteo RP, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ: The cost of postoperative pancreatic fistula versus the cost of pasireotide: Results from a prospective randomized trial. Ann Surg 265: 11-16, 2017.
  346. Zheng J, Kuk D, Gönen M, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, Jarnagin WR, DeMatteo RP: Actual 10-Year survivors after resection of hepatocellular carcinoma. Ann Surg Oncol 24: 1358-1366, 2017.
 
Publications
Editorials, Reviews, Chapters, including participation in committee reports (print or other media)
  1. Ahn M, Sohn C, Chang E, Chu G, DeMatteo RP, Barker CF.: Role of humoral immunity in pancreatic islet allo- and xenograft rejection. Transplant Proc 28: 840-1, 1996.
  2. Chu G, Markmann JF, Ahn M, Chang E, DeMatteo RP, Ketchum R, Brayman KL, Deng S, Barker CF: Xenogeneic but not allogeneic islet graft survival in recipients lacking humoralimmunity and major histocompatibility complex Class II antigens. Transplant Proc 29: 901-2, 1996.
  3. DeMatteo RP, Brennan MF, Lewis JJ: The role of surgery in the multidisciplinary treatment f extremity soft tissue sarcomas. Prob Gen Surg 16: 32-42, 1999.
  4. DeMatteo RP, Fong Y: Contemporary Imaging in Surgical Oncology. Surgical Oncology Clinics of North America. Kurtzmann S.  (eds.). 8: 59-89, 1999.
  5. DeMatteo RP: Invited editorial. An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to the portal bifurcation.  Arch Surg 135: 1279, 2000.
  6. DeMatteo RP, Fong Y: Molecular and genetic determinants of hepatobiliary and pancreatic neoplasia. Surgery of the Liver and Biliary Tract, 3rd Edition. Blumgart LH, Fong Y. (eds.). 2000.
  7. DeMatteo RP, Fong Y: Assessment of diagnostic techniques for biliary tract obstruction and liver masses. Surgery of the Liver and Biliary Tract 3rd Edition. Blumgart LH, Fong Y. (eds.). 2000.
  8. DeMatteo RP, Fong Y, Jarnagin WR, Blumgart LH: Recent advances in hepatic resection. Sem Surg Oncol 19: 200-207, 2000.
  9. Reeves M, DeMatteo RP: Genes and viruses in hepatobiliary neoplasia. Sem Surg Oncol 19(2): 84-93, 2000.
  10. DeMatteo RP, Blumgart LH: Techniques of major hepatic resection. Liver Surgery: Operative Techniques and Avoidance of Complications. Kockerling F., Schwartz SI. (eds.). 2001.
  11. DeMatteo RP, Blumgart LH: Management of malignant liver tumors. Current Surgical Therapy. Cameron JL. (eds.). 2001.
  12. DeMatteo RP, Fong Y: Gene transfer for the treatment of hepatic neoplasms.  Hepatobiliary Cancer. American Cancer Society Atlas of Clinical Oncology Series BC Decker 2001.
  13. Ruo L, DeMatteo RP, Blumgart LH: The role of adjuvant therapy after liver resection for colorectal cancer metastases. Clin Colorectal Cancer 1: 54-66, 2001.
  14. Smith A, DeMatteo RP, Fong Y, Blumgart L: Metastatic liver cancer. American Cancer Society  Atlas of Clinical Oncology Series. Blumgart LH, Fong Y, Jarnagin WR. (eds.). 2001.
  15. Cha C, DeMatteo RP, Blumgart LH: Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastro 35: S130-7, 2002.
  16. DeMatteo RP: The GIST of targeted cancer therapy: A tumor (gastrointestinal stromal tumor) a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol 9: 831-9, 2002.
  17. DeMatteo RP, Heinrich MC, El-Rifai WM, Demetri G: Clinical management of gastrointestinal stromal tumors: Before and after STI571. Human Pathol 33: 466-77, 2002.
  18. DeMatteo RP: Hepatic resection for colorectal liver metastases. Handbook of Hepatobiliary Surgery. Chamberlain R, Blumgart LH (eds.). 2003.
  19. DeMatteo RP, Fong Y: Surgical management of gallbladder cancer. Handbook of Hepatobiliary Surgery. Chamberlain R, Blumgart LH. (eds.). 2003.
  20. DeMatteo RP, Maki RG, Antonescu C, Brennan MF: Targeted molecular therapy for cancer: The application of STI571 to gastrointestinal stromal tumor. Curr Prob Surg 40: 144-93, 2003.
  21. Cha C, DeMatteo RP: Invited editorial. Pre-operative imaging vs pathologic findings after transplantation for HCC: Are current transplant criteria being met? Dig Dis Surg 2004.
  22. Cha C, DeMatteo RP, Blumgart LH: Surgical therapy for hepatocellular carcinoma. Adv Surg 38: 363-76, 2004.
  23. DeMatteo RP: 5 Chapters- Benign hepatic tumors. Cystic disease. Colorectal metastases. Hepatoma. Liver abscess. Palm Pilot Textbook of Surgery, Pocket Medicine.com, Inc., New York, NY. In: Lillemoe KD and Schulick RD. (eds.). 2004.
  24. DeMatteo RP, Blumgart LH: Newer techniques in liver resection.  Current Surgical Therapy. Mosby, St. Louis. In: Cameron JL. (eds.). 2004.
  25. DeMatteo RP, Brennan MF: The management of gastrointestinal stromal tumor.  Current Surgical Therapy. Mosby, St. Louis. In: Cameron JL. (eds.). 2004.
  26. Demetri GD, Benjamin R, Blanke CD, Choi H,Corless C, DeMatteo RP, Eisenberg BL, Fletcher CDM, Maki RG, Rubin B, Van den Abbeele AD, von Mehren M. : Optimal management of patients with gastrointestinal stromal tumors (GIST): Expansion and update of NCCN clinical practice guidelines. J Natl Compr Canc Netw 2(Suppl 1): 1-26, 2004.
  27. Liau K, Blumgart LH, DeMatteo RP: Segment-oriented approach to liver resection. Surg Clin N Am 84: 543-61, 2004.
  28. Bentrem D, DeMatteo RP, Blumgart LH: Surgical therapy for metastatic disease to the liver. Ann Rev Med 56: 139-56, 2005.
  29. Cha C, DeMatteo RP: Molecular mechanisms in hepatocellular carcinoma development.  Best Pract Res Clin Gastroenterol 19: 25-37, 2005.
  30. DeMatteo RP: Editorial. A little teaching pointfor the fellows. Surgery 138: 959-60, 2005.
  31. DeMatteo RP: Hepatic resection for the other metastases. Ann Surg Oncol 12: 763-4, 2005.
  32. Van der Zwan S, DeMatteo RP: Gastrointestinal stromal tumor: 5 years later. Cancer 104: 1781-8, 2005.
  33. Avital I, DeMatteo RP: Combined resection of liver and lung metastases for colorectal cancer. Thorac Surg Clin 16: 145-55, 2006.
  34. Gold JS, DeMatteo RP.: Combined surgical and molecular therapy: The gastrointestinal stromal tumor model. Ann Surg 244: 176-84, 2006.
  35. Liau KH, DeMatteo RP: Segment-oriented anatomic liver resections. Surgery of the Liver and Biliary Tract, 4th Edition. Harcourt Brace, Edinburgh. In: Blumgart LH, Belghiti J, Jarnagin WR, DeMatteo RP, Chapman WC, Buchler MW, Hann LE, D'Angelica M. (eds.). 2006.
  36. Pillarisetty V, DeMatteo RP: Liver immunology. Surgery of the Liver and Biliary Tract, 4 Edition. Harcourt Brace, Edinburgh. In: Blumgart LH, Belghiti J, Jarnagin WR, DeMatteo RP, Chapman WC, Buchler MW, Hann LE, D'Angelica M. (eds.). 2006.
  37. Weitz J, DeMatteo RP: Noncolorectal nonneuroendocrine metastases. Surgery of the Liver and Biliary Tract, 4th Edition. Harcourt Brace, Edinburgh. In: Blumgart LH, Belghiti J, Jarnagin WR, DeMatteo RP, Chapman WC, Buchler MW, Hann LE, D'Angelica M. (eds.). 2006.
  38. DeMatteo RP: Invited editorial. Treatment of advanced gastrointestinal stromal tumor: A marriage of targeted therapy and surgery? Ann Surg Oncol 14: 1-2, 2007.
  39. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP: NCCN Task Force report: Management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw(Suppl 2), S1-29, 2007.
  40. Gold JS, DeMatteo RP: Invited editorial. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): Racing against resistance. Ann Surg Oncol 14: 1247-8, 2007.
  41. You N, DeMatteo RP: Gastrointestinal stromal tumors (GIST): Surgery.  Gastro-intestinal Oncology: Evidence and Analysis. Dekker, Inc. In: McCulloch P, Kerr D, Karpeh M, Ajani J (eds). (eds.). 2007.
  42. D'Angelica M, Fong Y, DeMatteo RP, Jarnagin WR: Editorial. Hepatic arterial infusion chemotherapy for metastases for colorectal cancer: Is it really the end of an era? J Clin Oncol 26: 2788-90, 2008.
  43. Dalal KM, Antonescu CR, DeMatteo, RP, Maki RG: EBV-associated smooth muscle neoplasms: Solid tumors arising in the presence of immunosuppression and autoimmune diseases. Sarcoma 2008.
  44. DeMatteo RP: Cancer of the small bowel. Abeloff's Clinical Oncology, 4th Edition. Churchill Livingston, Philadelphia, PA. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG.  (eds.). 2008.
  45. DeMatteo RP: Surgery for colorectal liver metastases. Current Surgical Therapy, 9th Edition. Mosby, Philadelphia, PA. In: Cameron JL. (eds.). 2008.
  46. Gold JS, DeMatteo RP: Gastrointestinal stromal tumors. Surgery: Basic Science and Clinical Evidence, 2nd Edition. Springer-Verlag, New York. In: Norton JA, Barie PS, Bollinger R, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, Thompson RW. (eds.). 2008.
  47. Katz SC, DeMatteo RP: Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol 97: 350-9, 2008.
  48. Raut CP, DeMatteo RP: Invited editorial. Prognostic factors for primary GIST: Prime time for personalized therapy? Ann Surg Oncol 15: 4-6, 2008.
  49. Raut CP, DeMatteo RP: Invited editorial. Evidence-guided surgical management of GIST: Beyond a simple case of benign and malignant. Ann Surg Oncol 15: 1542-1543, 2008.
  50. Chaudhry UI, DeMatteo RP: Management of resectable gastrointestinal stromal tumor. Hematol Oncol Clin North Am 23: 79-96, 2009.
  51. DeMatteo RP: Invited editorial. Nano-neoadjuvant therapy of gastrointestinal stromal tumor. Ann Surg Oncol 16: 799-800, 2009.
  52. Kingham TP, DeMatteo RP.: Multidisciplinary treatment of gastrointestinal stromal tumors.  Surg Clin North Am 89: 217-33, 2009.
  53. Prete FP, DeMatteo RP: Gastrointestinal stromal tumors. General Surgery: Principles and International Practice, 2nd Edition. Wb Saunders, London, UK. In: Bland  (eds.). 2009.
  54. Demtri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PWT, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD.: NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw(Suppl 2), S1-41, 2010.
  55. Fields RC, DeMatteo RP: Incidentally discovered, intra-abdominal metallic foreign object on preoperative imaging. Am Surg 76: E180-1, 2010.
  56. Learn PA, Sicklick JK, DeMatteo RP: Randomized clinical trials in gastrointestinal stromal tumors. Surg Oncol Clin N Am 19: 101-113, 2010.
  57. Rubin RP, Blanke CD, Demetri GD, DeMatteo RP, Fletcher CD, Goldblum JR, Lasota J, Lazar A, Maki RG, Miettinen M, Noffsinger A, Washington MK, Krausz T, Cancer Committee, College of American Pathologists: Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch Pathol La Med 134: 165-70, 2010.
  58. Yopp AC, DeMatteo RP: Randomized clinical trials in surgical oncology. Preface. Surg Oncol Clin N Am 19: xv-vii, 2010.
  59. Chaudry UI, DeMatteo RP: Advances in the surgical management of gastrointestinal stromal tumor. Adv Surg 45: 197-209, 2011.
  60. Karakousis G, DeMatteo RP: Gastrointestinal stromal tumors.  Current Surgical Therapy, 10th Edition. Elsevier, Philadelphia, PA. In: Cameron JL and Cameron AM. (eds.). 2011.
  61. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M, Christophi C, Banting S, Brooke-Smith M, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Nimura Y, Figueras J, DeMatteo RP, Buchler MW, Weitz J: Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149: 680-8, 2011.
  62. Panait L, Learn P, Dimaio C, Klimstra D, Do KG, Schwarz T, D'Angelica M, DeMatteo RP, Kingham P, Allen P, Fong Y, Jarnagin WR.: Resection of perihilar biliary schwannoma. Surg Oncol 20: 157-9, 2011.
  63. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M,Adam R, Koch M, Makuuchi, DeMatteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Buchler MW, Weitz J.: Posthepatectomy liver failure: A definition and grading by International Study Group of Liver Surgery. Surgery 149: 713-24, 2011.
  64. Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, HughTJ, Fan ST, Nimura Y, Figueras J, Vauthey JN, Rees M, Adam R, DeMatteo RP, Greig P, Usatoff V, Banting S, Nagino M, Capussotti L, Yokoyama Y, Brooke-Smith M, Crawford M, Christophi C, Makuuchi M, Buchler MW, Weitz J. : Post-hepatectopmy haemorrhage: A definition and grading by the International Study Group of Liver Surgery. HPB 13: 528, 2011.
  65. Ammori JB, DeMatteo RP: Gastrointestinal stromal tumor. Clinical Scenarios in Surgery. Lippencott, Williams & Wilkins, Philadelphia, PA. In: Dimick JB, Upchurch Jr. GR, Sonnenday CJ. (eds.). 2012.
  66. Bamboat ZM, DeMatteo RP: Liver immunology. Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas, 5th Edition Harcourt Brace, Edinburgh. Jarnagin WR, Belghiti J, Buchler MW, Chapman WC, D'Angelica MI, DeMatteo RP, Hann LE. (eds.). 2012.
  67. Bamboat ZM, DeMatteo RP: Updates on the management of gastrointestinal stromal tumors (GIST). Surg Oncol Clin N Am 21: 301-16, 2012.
  68. Baxi SS, Sherman EJ, KElly Kw, Brown KT, DeMatteo RP, Pfister DG: Hemorraghic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancer. Thyroid 22: 552-5, 2012.
  69. DeMatteo RP: Personalized Therapy: Prognostic factors in gastrointestinal stromal tumors (GIST). J Gastrointest Surg 16: 1645-7, 2012.
  70. DeMatteo RP: Invited editorial of the book "Venous embolization of the liver: Radiological and Surgical Practice." Gastroenterology 143: 266-7, 2012.
  71. Joensuu H, DeMatteo RP: The management of gastrointestinal stromal tumors: A model for targeted and multidisciplinary therapy of malignancy. Ann Rev Med 63: 247-58, 2012.
  72. Turcotte S, DeMatteo RP: Resection versus transplantation for early hepatocellular carcinoma: More art than science. Ann Surg 256: 892-3, 2012.
  73. Weitz J, DeMatteo RP: Noncolorectal nonneuroendocrine metastases. Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas, 5th EditionHarcourt Brace, Edinburgh. In: Jarnagin WR, Belghiti J, Buchler MW, Chapman WC, D'Angelica MI, DeMatteo RP, Hann LE. (eds.). 2012.
  74. Balachandran VP, DeMatteo RP: Targeted therapy for cancer: The gastrointestinal stromal tumor model. Surg Oncol Clin N Am 22: 805-21, 2013.
  75. Bamboat ZM, DeMatteo RP: Gastrointestinal stromal tumor. Clinical Support System on Surgery. Decision Support System in Medicine, LLC. In: Lillemoe K, de Moya M, House M, and Hutter M.  (eds.). 2013.
  76. DeMatteo RP: Perspective on gastrointestinal stromal tumors. Maingot's Abdominal Operations 12th Edition. McGraw Hill Company. New York, NY 2013. In: Zinner MJ and Ashley SW. (eds.). 2013.
  77. Kingham TP, DeMatteo RP: Treatment of liver cysts. Master Techniques in Surgery Hepatobiliary and Pancreatic Surgery. Lippencott Williams & Wilkins. Philadelphia, PA  In: Lillemoe K and Jarnagin W. (eds.). 2013.
  78. Balachandran VP, DeMatteo RP: Gastrointestinal stromal tumors: Who should get imatinib and for how long? Adv Surg 48: 165-83, 2014.
  79. Balachandran VP, DeMatteo RP: Adjuvant imatinib for GIST: The pie is shrinking. Ann Surg Oncol 21: 3365-6, 2014.
  80. Balachandran VP, DeMatteo RP: Surgical management of GIST. Sarcoma Oncology. People's Medical Publishing House- USA, Ltd. Shelton, CT. In: Pollock RE, Randall RL, O'Sullivan B, Barker LH. (eds.). 2014.
  81. Bamboat ZM, DeMatteo RP: Metastasectomy for gastrointestinal stromal tumor. J Surg Oncol 109: 23-7, 2014.
  82. Bello DM, DeMatteo RP, Ariyan CE: The GIST of targeted therapy for malignant melanoma. Ann Surg Oncol 2: 2059-67, 2014.
  83. Cavnar MJ, DeMatteo RP: Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages. Oncoimmunology 3: e28463, 2014.
  84. Correa-Gallego C, Brennan MF, Fong Y, Kingham TP, DeMatteo RP, D'Angelica MI, Jarnagin WR, Allen PJ. : Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasm- also not harmless. Ann Surg 259: e45, 2014.
  85. Sotirchos VS, Petre EN, Brown KT, Brody LA, D'Agelica MI, DeMatteo RP, Kemeny NE, Sofocleous CT: Safe and successful Yttrium-90 resin microsphere radioembolization in a heavily pretreated patient with chemorefractory colorectal Liver metastases after biliary stent placement above the papilla. Case Reports Hepatol Page: 921406, 2014.
  86. Antonescu CR, DeMatteo RP: CCR 20th Anniversary Commentary: A genetic mechanism of imatinib resistance in gastrointestinal stromal tumor- Where are we a decade later? Clin Cancer Res 21: 3363-5, 2015.
  87. Balachandran VP, Gonen M, Smith JJ, DeMatteo RP: Nomograms in oncology: more than meets the eye. Lancet Oncol 16: e173-80, 2015.
  88. Baselga J, Bhardwaj N, Cantley LC, DeMatteo RP, Dubois RN, Foti M, Gapstur SM, Hahn WC, Helman LJ, Jensen RA, Paskett ED, Lawrence TS, Lutzker SG, Szabo E. : AACR cancer progress report. Clin Cancer Res  21: S1-128, 2015.
  89. Agulnik M, Asare EA, Baldini EH, Brookland RK, Cooper K, DeMatteo RP, Folpe Al, Guadagnolo BA, Hornick JL, Jones RL, Keedy VL, Kirsch DG, Lazar AJ, Madewell JE, Maki RG, O'Sullivan B, Panicek DM, Patel SG, Pollock RE, Randall RL, Raut CP, Sturgis EM, Tedder Ps, Yoon SS.: Soft tissue sarcoma. American Joint Commission on Cancer (AJCC) Staging Manual, 7th Edition 2016.
  90. Blanke CD, DeMatteo RP: Invited editorial. Duration of adjuvant therapy  for GIST: Where is Goldilocks when we need her? JAMA Oncol 2: 721-2, 2016.
  91. Blumgart LH, Schwartz LH, DeMatteo RP: Surgical and radiologic anatomy of the liver, biliary tract, and pancreas.  Blumgart's Surgery of Liver, Biliary Tract, and Pancreas, 6th Edition Elsevier. In: Jarnagin WR, Allen PJ, Chapman WC, D'Angelica MI, DeMatteo RP, Do RKG, Vauthey JN.  (eds.). 2016.
  92. Cohen N, Kim T, DeMatteo RP: Principles of kinase inhibitor therapy for solid tumors. Ann Surg 2016.
  93. Katz SC, Bamboat ZM, Pillarisetty VG, DeMatteo RP: Liver immunology.  Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 6th Edition. Elsevier. In: Jarnagin WR, Allen PJ, Chapman WC, D'Angelica MI, DeMatteo RP, Do RKG, Vauthey JN. (eds.). 2016.
  94. Lee A, Huang P, DeMatteo RP, Pollack SM: Immunotherapy for soft tissue sarcoma: Tomorrow is only a day away. Am Soc Clin Oncol Educ Book 35: 281-90, 2016.
  95. Cavnar MJ, and DeMatteo RP: The management of gastrointestinal stromal tumors. Current Surgical Therapy, 12th Edition. Elselvier Saunders. Philadelphia, PA. In: J. Cameron, A. Cameron. (eds.). 2017.
  96. Cavnar MJ, DeMatteo RP: Perspective on gastrointestinal stromal tumors.  Magnicot's Abdominal Operations, 13th Edition. New York: McGraw-Hill  In: M Zinner, S Ashley. (eds.). in press.
  97. Sicklick JK, Babicky M, DeMatteo RP: Resection of non-adenomatous gastric tumors. Operative Endoscopic and Minimally Invasive Surgery. CRC Press. Abingdon, UK. InL: Jones DB and Schwaitzberg SD. (eds.). in press.
Books
  1. Abou-Alfa GK, DeMatteo RP: 100 questions and answers about liver cancer. Jones and Bartlett Publishers 2006.
  2. Blumgart LH, Belghiti J, Jarnagin WR, DeMatteo RP, Chapman WC, Buchler MW, Hann LE: Surgery of the Liver and Biliary Tract 4th Edition. Elsevier, Amsterdam, Netherlands. D'Angelica M (eds.). 2006.
  3. DeMatteo RP, Symcox M, Demetri GD: 100 questions and answers about gastrointestinal stromal tumors (GIST).  Jones and Bartlett Publishers 2007.
  4. Abou-Alfa GK, DeMatteo RP: 100 questions & answers about liver cancer. 2nd Edition. Jones and Bartlett Publishers 2008.
  5. Abou-Alfa GK, DeMatteo RP: 100 questions and answers about liver cancer. 3rd Edition. Jones and Bartlett Publishers 2012.
  6. Jarnagin WR, Belghiti J, Buchler MW, Chapman WC, D'Angelica MI, DeMatteo RP: Blumgart's Surgery in Liver, Biliary Tract, and Pancreas, 5th Edition. Elsevier, Amsterdam Netherlands. Hann LE (eds.). 2012.
  7. Jarnagin WR, Allen PJ, Chapman WC, D'Angelica MI, DeMatteo RP, Do RKG: Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 6th Edition. Elsevier, Amsterdam, Netherlands. Vauthey JN (eds.). 2016.
 
Awards, Honors and Membership in Honorary Societies
2016 Jeroen Pit Science Award, The GIST Life Raft Support Group
 
2015 - present Castle Connolly/Newsweek America's Top Doctors for Cancer
 
2014 - present New York Magazine Best Doctors
 
2013 - present Castle Connolly/U.S. News and World America's Top Doctors
 
2008 - 2010 Society of Surgical Oncology Clinical Investigator Award
 
2004 Louise and Alston Boyer Young Investigator Award for Research, Memorial Hospital
 
2002 - 2003 Traveling Fellowship to England and Scotland
The Royal College of Surgeons Foundation
 
2000 - 2002 Society for Surgery of the Alimentary Tract Career Development Award
 
1999 Michael E. Burt MD, PhD Memorial Award for Clinical Excellence by a Surgical Fellow
Department of Surgery, Memorial Hospital
New York, New York
 
1997 Leonard J. Perloff, M.D. Chief Resident Teaching Award (voted by surgical housestaff)
Hospital of the University of Pennsylvania
 
1996 British Journal of Surgery Award for Outstanding Surgical Resident
Hospital of the University of Pennsylvania
 
1995 Jonathan E. Rhoads, M.D. Research Award, Department of Surgery
Hospital of the University of Pennsylvania
 
1994 - 1996 National Institutes of Health National Research Service Award
 
1991 - 1997 Scored in top tenth percentile each year on American Board of Surgery-in-Training Exam
 
1990 Alpha Omega Alpha Honor Society, Cornell University Medical College
 
1986 Phi Beta Kappa Honor Society, The Johns Hopkins University Chapter
 
1983 Cum Laude Honor Society, Montclair, New Jersey Chapter

Ron DeMatteo

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine